المؤلفون: I. V. Dmitriev, N. V. Borovkova, S. P. Shchelykalina, N. V. Doronina, N. S. Zhuravel, A. V. Pinchuk, И. В. Дмитриев, Н. В. Боровкова, С. П. Щелыкалина, Н. В. Доронина, Н. С. Журавель, А. В. Пинчук

المصدر: Transplantologiya. The Russian Journal of Transplantation; Том 14, № 3 (2022); 254-264 ; Трансплантология; Том 14, № 3 (2022); 254-264 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2022-14-3

مصطلحات موضوعية: острое отторжение, transplant immunology, de novo anti-HLA antibodies, pretransplant anti-HLA antibodies, acute rejection, трансплантационная иммунология, предсуществующие анти-HLA-антитела, вновь образованные антитела против HLA, de novo анти-HLA-антитела

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/682/704; Parajuli S, Alagusundaramoorthy S, Aziz F, Garg N, Redfield RR, Sollinger H, et al. Outcomes of pancreas transplant recipients with de novo donor-specific antibodies. Transplantation. 2019;103(2):435–440. PMID: 29994978 https://doi.org/10.1097/TP.0000000000002339; Malheiro J, Martins LS, Tafulo S, Dias L, Fonseca I, Beirão I, et al. Impact of de novo donor-specific anti-HLA antibodies on grafts outcomes in simultaneous pancreas-kidney transplantation. Transpl Int. 2016;29(2):173–183. PMID: 26404891 https://doi.org/10.1111/tri.12687; Cantarovich D, De Amicis S, Akl A, Devys A, Vistoli F, Karam G, et al. Posttransplant donor-specific anti-HLA antibodies negatively impact pancreas transplantation outcome. Am J Transplant. 2011;11(12):2737–2746. PMID: 21906255 https://doi.org/10.1111/j.1600-6143.2011.03729.x; Aziz F, Mandelbrot D, Parajuli S, Al-Qaoud T, Redfield R, Kaufman D, et al. Alloimmunity in pancreas transplantation. Curr Opin Organ Transplant. 2020;25(4):322–328. PMID: 32692039 https://doi.org/10.1097/MOT.0000000000000776; Mittal S, Page SL, Friend PJ, Sharples EJ, Fuggle SV. De novo donor-specific HLA antibodies: biomarkers of pancreas transplant failure. Am J Transplant. 2014;14(7):1664–1671. PMID: 24866735 https://doi.org/10.1111/ajt.12750; Ladowski JM, Mullins H, Romine M, Kloda D, Young C, Hauptfeld-Dolejsek V, et al. Eplet mismatch scores and de novo donor-specific antibody development in simultaneous pancreas-kidney transplantation. Hum Immunol. 2021;82(3):139–146. PMID: 33390268 https://doi.org/10.1016/j.humimm.2020.12.009; Khan SM, Sumbal R, Schenk AD. Impact of anti-HLA de novo donor specific antibody on graft outcomes in pancreas transplantation: a meta-analysis. Transplant Proc. 2021;53(10):3022–3029. PMID: 34772490 https://doi.org/10.1016/j.transproceed.2021.08.052; Bouquegneau A, Loheac C, Aubert O, Bouatou Y, Viglietti D, Empana JP, et al. Complement-activating donorspecific anti-HLA antibodies and solid organ transplant survival: a systematic review and meta-analysis. PLoS Med. 2018;15(5):e1002572. https://doi.org/10.1371/journal.pmed.1002572 Erratum in: PLoS Med. 2018;15(7):e1002637. PMID: 29799874.; Perosa M, Vidigal AC, Danziere F, De Marco R, Malheiros D, Branez J, et al. 306.5: a prospective study of donorspecific anti-HLA antibody monitoring in pancreas transplantation. Transplantation. 2021;105(12Suppl 1):S20. PMID: 34908324 https://doi.org/10.1097/01.tp.0000804388.98141.6e; Chaigne B, Geneugelijk K, Bédat B, Ahmed MA, Hönger G, De Seigneux S, et al. Immunogenicity of anti-HLA antibodies in pancreas and islet transplantation. Cell Transplant. 2016;25(11):2041–2050. PMID: 27196533 https://doi.org/10.3727/096368916X691673; Mujtaba MA, Fridell JA, Higgins N, Sharfuddin AA, Yaqub MS, Kandula P, et al. Early findings of prospective antiHLA donor specific antibodies monitoring study in pancreas transplantation: Indiana University Health Experience. Clin Transplant. 2012;26(5):E492–499. PMID: 22938159 https://doi.org/10.1111/ctr.12005; Baranwal AK, Mehra NK. Major histocompatibility complex class I chainrelated A (MICA) molecules: relevance in solid organ transplantation. Front Immunol. 2017;8:182. PMID: 28293239 https://doi.org/10.3389/fimmu.2017.00182; Зайцева Г.А., Киселева А.Н., Парамонов И.В. Полиморфизм генов MICA и MICB в комплексе МНС. Гематология и трансфузиология. 2016;61(2):100–104. https://doi.org/10.18821/0234-5730-2016-61-2-100-104; https://www.jtransplantologiya.ru/jour/article/view/682

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/682
https://doi.org/10.23873/2074-0506-2022-14-3-254-264

المؤلفون: D. A. Velikiy, O. E. Gichkun, S. O. Sharapchenko, N. P. Mozheiko, R. M. Kurabekova, O. P. Shevchenko, Д. А. Великий, О. Е. Гичкун, С. О. Шарапченко, Н. П. Можейко, Р. М. Курабекова, О. П. Шевченко

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 22, № 4 (2020); 20-26 ; Вестник трансплантологии и искусственных органов; Том 22, № 4 (2020); 20-26 ; 2412-6160 ; 1995-1191 ; 10.15825/1995-1191-2020-4

مصطلحات موضوعية: биомаркеры, miRNA-101, miRNA-27, acute rejection, biomarkers, микроРНК-101, микроРНК-27, острое отторжение

وصف الملف: application/pdf

Relation: https://journal.transpl.ru/vtio/article/view/1258/1040; https://journal.transpl.ru/vtio/article/view/1258/1126; Готье СВ, Шевченко АО, Попцов ВН. Пациент с трансплантированным сердцем: руководство для врачей по ведению пациентов, перенесших трансплантацию сердца. М.: Триада, 2014. 144.; Шевченко АО, Никитина ЕА, Колоскова НН, Шевченко ОП, Готье СВ. Контролируемая артериальная гипертензия и выживаемость без нежелательных событий у реципиентов сердца. Кардиоваскулярная терапия и профилактика. 2018; 17 (4): 4–11.; Stehlik J, Starling RC, Movsesian MA, Fang JC, Brown RN, Hess ML et al. Cardiac Transplant Research Database Group. Utility of long-term surveillance endomyocardial biopsy: a multi-institutional analysis. J Heart Lung Transplant. 2006; 25 (12): 1402–1409.; Crespo-Leiro MG, Barge-Caballero G, Couto-Mallon D. Noninvasive monitoring of acute and chronic rejection in heart transplantation. Curr Opin Cardiol. 2017; 32 (3): 308–315.; Шумаков ВИ, Шевченко ОП, Хубутия МШ, Орлова ОВ, Казаков ЭН, Кормер АЯ, Олефиренко ГА. Васкулопатия трансплантированного сердца: синергизм провоспалительных, проатерогенных факторов и вирусной инфекции. Вестник Российской академии медицинских наук. 2006; 11: 8–14.; Savic-Radojevic A, Pljesa-Ercegovac M, Matic M et al. Novel biomarkers of heart failure. Advances In Clinical Chemistry. 2017; 79: 93–152.; Kransdorf EP, Kobashigawa JA. Novel molecular approaches to the detection of heart transplant rejection. Per Med. 2017 Jul; 14 (4): 293–297.; van Gelder T. Biomarkers in solid organ transplantation. Br J Clin Pharmacol. 2017 Dec; 83 (12): 2602–2604.; Starling RC, Stehlik J, Baran DA et al. Multicenter analysis of immune biomarkers and heart transplant outcomes: results of the clinical trials in organ transplantation-05 study. American Journal of Transplantation. 2016; 16: 121–136.; Di Francesco A, Fedrigo M, Santovito D, Natarelli L, Castellani C, De Pascale F et al. MicroRNA signatures in cardiac biopsies and detection of allograft rejection. J Heart Lung Transplant. 2018 Nov; 37 (11): 1329–1340.; Shah P, Bristow MR, Port JD. MicroRNAs in Heart Failure, Cardiac Transplantation, and Myocardial Recovery: Biomarkers with Therapeutic Potential. Curr Heart Fail Rep. 2017 Dec; 14 (6): 454–464.; Khush K, Zarafshar S. Molecular Diagnostic Testing in Cardiac Transplantation. Curr Cardiol Rep. 2017 Oct 13; 19 (11): 118.; Великий ДА, Гичкун ОЕ, Шарапченко СО, Шевченко ОП, Шевченко АО. Уровень экспрессии микроРНК в ранние и отдаленные сроки после трансплантации у реципиентов сердца. Вестник трансплантологии и искусственных органов. 2020; 22 (1): 26–34.; Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001 Dec; 25 (4): 402–408.; Li X, Zhang S, Wa M, Liu Z, Hu S. microRNA-101 Protects Against Cardiac Remodeling Following Myocardial Infarction via Downregulation of Runt-Related Transcription Factor 1. J Am Heart Assoc. 2019 Dec 3; 8 (23): e013112.; Huang C, Xiao X, Yang Y, Mishra A, Liang Y, Zeng X et al. MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation. J Biol Chem. 2017 Oct 6; 292 (40): 16420–16439.; Meroni M, Longo M, Erconi V, Valenti L, Gatti S, Fracanzani AL, Dongiovanni P. Mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance. Nutrients. 2019 Oct 29; 11 (11): 2597.; Zhang XL, An BF, Zhang GC. MiR-27 alleviates myocardial cell damage induced by hypoxia/reoxygenation via targeting TGFBR1 and inhibiting NF-κB pathway. Kaohsiung J Med Sci. 2019 Oct; 35 (10): 607–614.; Wang Y, Cai H, Li H, Gao Z, Song K. Atrial overexpression of microRNA-27b attenuates angiotensin II-induced atrial fibrosis and fibrillation by targeting ALK5. Hum Cell. 2018 Jul; 31 (3): 251–260.; Hughes G. Youden’s Index and the Weight of Evidence Revisited. Methods Inf Med. 2015; 54 (6): 576–577.; https://journal.transpl.ru/vtio/article/view/1258

الاتاحة: https://journal.transpl.ru/vtio/article/view/1258
https://doi.org/10.15825/1995-1191-2020-4-20-26

المؤلفون: A. Pinchuk V., N. Shmarina V., I. Dmitriev V., E. Stolyarevich S., N. Natalya V. Zagorodnikova V., K. Lazareva E., А. Пинчук В., Н. Шмарина В., И. Дмитриев В., Е. Столяревич С., Н. Загородникова В., К. Лазарева Е.

المصدر: Transplantologiya. The Russian Journal of Transplantation; Том 13, № 3 (2021); 260-271 ; Трансплантология; Том 13, № 3 (2021); 260-271 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2021-13-3

مصطلحات موضوعية: acute rejection of the kidney graft, repeat kidney transplantation, kidney graft survival, острое отторжение трансплантата почки, повторная трансплантация почки, выживаемость трансплантата почки

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/586/637; https://www.jtransplantologiya.ru/jour/article/view/586/642; Naik RH, Shawar SH. Renal Transplantation Rejection. In: StatPearls [Internet]. Treasure Island (FL): Stat- Pearls Publishing; 2020. PMID: 3197171 Available at: https://pubmed.ncbi.nlm.nih.gov/31971715/ [Accessed April 9, 2021].; Djamali A, Kaufman DB, Ellis TM, Zhong W, Matas A, Samaniego M. Diagnosis and management of antibodymediated rejection: current status and novel approaches. Am J Transplant. 2014;14(2):255–721. PMID: 24401076 https://doi.org/10.1111/ajt.12589; Halloran PF, Reeve JP, Pereira AB, Hidalgo LG, Famulski KS. Antibodymediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies. Kidney Int. 2014;85(2):258–264. PMID: 23965521 https://doi.org/10.1038/ki.2013.300; Larpparisuth N, Vongwiwatana A, Vareesangthip K, Cheunsuchon B, Parichatikanon P, Premasathian N. Clinicopathologic features and treatment response of early acute antibody-mediated rejection in Thai kidney transplant recipients: a single-center experience. Transplant Proc. 2014;46(2):474–476. PMID: 24655992 https://doi.org/10.1016/j.transproceed.2013.12.022; Gubensek J, Buturovic-Ponikvar J, Kandus A, Arnol M, Lindic J, Kovac D, et al. Treatment of antibody-mediated rejection after kidney transplantation – 10 years' experience with apheresis at a single center. Ther Apher Dial. 2016;20(3):240–245. PMID: 27312908 https://doi.org/10.1111/1744-9987.12430; Rodríguez Cubillo B, Pérez Flores I, Calvo N, Pascual A, Cortés JA, Moreno MA, et al. Antibody-mediated acute vascular rejection of kidney allografts: fifteen-year follow-up. Transplant Proc. 2016;48(9):2917–2919. PMID: 27932107 https://doi.org/10.1016/j.transproceed.2016.09.015; Nanmoku K, Shinzato T, Kubo T, Shimizu T, Yagisawa T. Effect of rabbit antithymocyte globulin on acute and chronic active antibody-mediated rejection after kidney transplantation. Transplant Proc. 2019;51(8):2602–2605. PMID: 31324482 https://doi.org/10.1016/j.transproceed.2019.02.051; Clayton PA, McDonald SP, Russ GR, Chadban SJ. Long-term outcomes after acute rejection in kidney transplant recipients: an ANZDATA analysis. J Am Soc Nephrol. 2019;30(9):1697– 1707. PMID: 31308074 https://doi.org/10.1681/ASN.2018111101; Davis S, Cooper JE. Acute antibodymediated rejection in kidney transplant recipients. Transplant Rev (Orlando). 2017;31(1):47–54. PMID: 28126347 https://doi.org/10.1016/j.trre.2016.10.004; Solez K, Racusen LC. The Banff classification revisited. Kidney Int. 2013;83(2):201–206. PMID: 23235566 https://doi.org/10.1038/ki.2012.395; Roufosse C, Simmonds N, Groningen MC-van, Haas M, Henriksen KJ, Horsfield C, et al. A 2018 reference guide to the Banff classification of renal allograft pathology. Transplantation. 2018;102(11):1795–1814. PMID: 30028786 https://doi.org/10.1097/TP.0000000000002366; Banff foundation for allograft pathology. Available at: https://banfffoundation.org [Accessed April 9, 2021].; Morris PJ, Knechtle SJ. Kidney transplantation: principles and practice. 7th ed. Elsevier Science; 2013.; Comai G, Ravaioli M, Baraldi O, Cuna V, Gasperoni L, D''Arcangelo GL, et al. Treatment of Acute Antibody-Mediated Rejection. Contrib Nephrol. 2017;190:156-167. PMID: 28535527 https://doi.org/10.1159/000468962; Zhang R. Donor-specific antibodies in kidney transplant recipients. Clin J Am Soc Nephrol. 2018;13(1):182–192. PMID: 28446536 https://doi.org/10.2215/CJN.00700117; Cooper JE. Evaluation and treatment of acute rejection in kidney allografts. Clin J Am Soc Nephrol. 2020;15(3):430– 438. PMID: 32066593 https://doi.org/10.2215/CJN.11991019; https://www.jtransplantologiya.ru/jour/article/view/586

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/586
https://doi.org/10.23873/2074-0506-2021-13-3-260-271

المؤلفون: O. P. Shevchenko, A. A. Ulybysheva, N. P. Mozheiko, O. E. Gichkun, E. A. Stakhanova, V. P. Vasilieva, A. O. Shevchenko, О. П. Шевченко, А. А. Улыбышева, Н. П. Можейко, О. Е. Гичкун, Е. А. Стаханова, В. П. Васильева, А. О. Шевченко

المساهمون: Исследование профинансировано грантом Президента Российской Федерации НШ-2598.2020.7 для государственной поддержки ведущих научных школ РФ.

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 22, № 1 (2020); 8-15 ; Вестник трансплантологии и искусственных органов; Том 22, № 1 (2020); 8-15 ; 2412-6160 ; 1995-1191 ; 10.15825/1995-1191-2020-1

مصطلحات موضوعية: диагностическая значимость, galectin-3, myocardial fibrosis, acute rejection, diagnostic value, галектин‑3, фиброз миокарда, острое отторжение

وصف الملف: application/pdf

Relation: https://journal.transpl.ru/vtio/article/view/1138/900; https://journal.transpl.ru/vtio/article/view/1138/947; Шевченко АО, Никитина ЕА, Колоскова НН, Шевченко ОП, Готье СВ. Контролируемая артериальная гипертензия и выживаемость без нежелательных событий у реципиентов сердца. Кардиоваскулярная терапия и профилактика. 2018; 17 (4): 4–11.; Lok SI, Nous FM, van Kuik J et al. Myocardial fibrosis and pro-fibrotic markers in end-stage heart failure patients during continuous-flow left ventricular assist device support. Eur J Cardiothorac Surg. 2015; 48: 407–415.; Ahmad T, Wang T, O’Brien EC et al. Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury. J Am Coll Cardiol HF. 2015; 3: 30–39.; Dumic J, Dabelic S, Flogel M. Galectin‑3: an open-ended story. Biochim Biophys Acta. 2006. 1760: 6616–6635.; González A, Schelbert EB, Díez J, Butler J. Myocardial Interstitial Fibrosis in Heart Failure: Biological and Translational Perspectives. J Am Coll Cardiol. 2018; 71 (15): 1696–1706. doi:10.1016/j.jacc.2018.02.02.; Драпкина ОМ, Деева ТА. Галектин‑3 – биомаркер фиброза у пациентов с метаболическим синдромом. Российский кардиологический журнал. 2015; 9 (125): 96–102.; Шевченко ОП, Улыбышева АА, Гичкун ОЕ, Можейко НП, Стаханова ЕА, Кван ВС, Шевченко АО. Галектин‑3 при отторжении и фиброзе трансплантированного сердца. Вестник трансплантологии и искусственных органов. 2019; 21 (3): 62–68. https://doi.org/10.15825/1995-1191-2019‑3-62-68.; Готье СВ, Шевченко АО, Попцов ВН. Пациент с трансплантированным сердцем. М.–Тверь: Триада, 2014: 144.; González A, López B, Ravassa S, San José G, Díez J. The Complex Dynamics of Myocardial Interstitial Fibrosis in Heart Failure. Focus on Collagen Cross-Linking. Biochim Biophys Acta Mol Cell Res. 2019; 1866 (9): 1421–1432.; Wan YJ, Guo Q, Liu D, Jiang Y. Protocatechualdehyde reduces myocardial fibrosis by directly targeting conformational dynamics of collagen. Eur J Pharmacol. 2019; 855: 183–191.; Gyongyosi M, Winkler J, Ramos I, et al. Myocardial fibrosis: biomedical research from bench to bedside. Eur J Heart Fail. 2017; 19 (2): 177–191. doi:10.1002/ejhf.696.; Kyselovic J, Leddy JJ. Cardiac Fibrosis: The Beneficial Effects of Exercise in Cardiac Fibrosis. Exercise for Cardiovascular Disease Prevention and Treatment: From Molecular to Clinical. 2017; Part 1: 257–268. doi:10.1007/978-981-10-4307-9_14.; https://journal.transpl.ru/vtio/article/view/1138

الاتاحة: https://journal.transpl.ru/vtio/article/view/1138
https://doi.org/10.15825/1995-1191-2020-1-8-15

المؤلفون: I. A. Pirozhkov, M. E. Malyshev, O. N. Reznik, V. A. Manukovsky, A. E. Skvortsov, И. А. Пирожков, М. Е. Малышев, О. Н. Резник, В. А. Мануковский, А. Е. Скворцов

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 20, № 3 (2018); 87-94 ; Вестник трансплантологии и искусственных органов; Том 20, № 3 (2018); 87-94 ; 2412-6160 ; 1995-1191 ; 10.15825/1995-1191-2018-3

مصطلحات موضوعية: острое отторжение трансплантата, kidney transplantation, acute kidney injury, acute allograft rejection, трансплантация почки, острое повреждение почки

وصف الملف: application/pdf

Relation: https://journal.transpl.ru/vtio/article/view/917/736; Williams WW, Taheri D, Tolkoff-Rubin N, Colvin RB. Clinical role of the renal transplant biopsy. Nat. Rev. Nephrol. 2012; 8 (2): 110–121.; Serуn D, Moreso F. Protocol biopsies in renal transplantation: prognostic value of structuralmonitoring. Kidney Int. 2007; 72 (6): 690–697.; Kozakowski N, Regele H. Biopsy diagnostics in renal allograft rejection: from histomorphology to biological function. Transpl. Int. 2009; 22 (10): 945–953.; Gwinner W. Renal transplant rejection markers. World J. Urol. 2007; 25: 445–455.; Knoll GA. Proteinuria in kidney transplant recipients: prevalence, prognosis, and evidence-based management. Am. J. Kidney Dis. 2009; 54 (6): 1131–1144.; Buob D, Grimbert P, Glowacki F, Labalette M, Dufossé F, Nochy D et al. Three-year outcome of isolated glomerulitis on 3-month protocol biopsies of donor HLA antibody negative patients. Transpl. Int. 2012; 25 (6): 663–670.; Willicombe M, Roufosse C, Brookes P, McLean AG, Galliford J, Cairns T et al. Acute cellular rejection: impact of donor-specific antibodies and C4d. Transplantation. 2014; 97: 433–439.; Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ et al. The microRNA spectrum in 12 body fluids. Clin. Chem. 2010; 56 (11): 1733–1741.; Allegra A1, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D et al. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review). Int. J. Oncol. 2012; 41 (6): 1897–1912.; Xiao YF, Yong X, Fan YH, Lü MH, Yang SM, Hu CJ. MicroRNA detection in feces, sputum, pleural effusion and urine: novel tools for cancer screening (Review). Oncol. Rep. 2013; 30 (2): 535–544.; Chekulaeva M, Filipowicz W. Mechanisms of miRNA mediated post-transcriptional regulation in animal cells. Current Opinion in Cell Biology. 2009; 21 (3): 452–460.; Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116; 2: 281–297.; Аушев ВН. Микро-РНК: малые молекулы с большим значением. Клин. онкогематол. 2015; 8 (1): 1–12. Aushev VN. MicroRNA: small molecules of great significance. Klin. onkogematol. 2015; 8 (1): 1–12.; Zhuo Y, Gao G, Shi JA, Zhou X, Wang X. miRNAs: biogenesis, origin and evolution, functions on virus-host interaction. Cell. Physiol. Biochem. 2013; 32 (3): 499–510.; Ha M, Kim VN. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell. Biol. 2014; 15 (8): 509–524.; Dalmay T. Mechanism of miRNA-mediated repression of mRNA translation. Essays Biochem. 2013; 54: 29–38.; Valinezhad Orang A, Safaralizadeh R, Kazemzadeh-Bavili M. Mechanisms of miRNA- mediated gene regulation from common downregulation to mRNA-Specific upregulation. Int. J. Genomics. 2014:970607.; Lodish HF, Zhou B, Liu G, Chen CZ. Micromanagement of the immune system by miRNAs. Nat. Rev. Immunol. 2008; 8 (2): 120–130.; Spiegel JC, Lorenzen JM, Thum T. Role of miRNAs in immunity and organ transplantation. Expert Rev. Mol. Med. 2011; 13: e37.; Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J. Clin. Invest. 2004; 114 (1): 5–14.; Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care (London, England). 2004; 8 (4).; Смирнов АВ, Добронравов ВА, Румянцев АШ, Шилов ЕМ, Ватазин АВ, Каюков ИГ и др. Национальные рекомендации. Острое повреждение почек: основные принципы диагностики, профилактики и терапии. Часть I. Нефрология. 2016; 20 (1): 79–104. Smirnov AV, Dobronravov VA, Rumyantsev AS, Shilov EM, Vatazin AV, Kayukov IG et al. National guidelines. Acute kidney injury: basic principles of diagnosis, prevention and therapy. Part I. Nephrology. 2016; 20 (1): 79–104.; Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet. 2004; 364: 1814–1827.; Siedlecki A, Irish W, Brennan DC. Delayed graft function in the kidney transplant. Am. J. Transplant. 2011; 11: 2279–2296.; Yarlagadda SG, Coca SG, Formica RN Jr, Poggio ED, Parikh CR. Association between delayed graft function and allograft and patient survival: asystematic review and meta- analysis. Nephrol. Dial. Transplant. 2009; 24: 1039–1047.; Legendre C, Canaud G, Martinez F. Factors influencing long-term outcome after kidney transplantation. Transpl. Int. 2014; 27 (1): 19–27.; Eltzschig HK, Eckle T. Ischemia and reperfusion – from mechanism to translation. Nat. Med. 2011; 17 (11): 1391–1401.; Godwin JG, Ge X, Stephan K, Jurisch A, Tullius SG, Iacomini J. Identification of a microRNA signature of renal ischemia reperfusion injury. Proc. Natl. Acad. Sci. USA. 2010; 107 (32): 14339–14344.; Zarjou A, Yang S, Abraham E, Agarwal A, Liu G. Identification of a microRNA signature in renal fibrosis: role of miR-21. Am. J. Physiol. Renal. Physiol. 2011; 301 (4): 793–801.; Saikumar J, Hoffmann D, Kim TM, Gonzalez VR, Zhang Q, Goering PL et al. Expression, circulation and excretion profile of microRNA-21, -155, and -18a following acute kidney injury. Toxicol. Sci. 2012; 129 (2): 256–267.; Yinfeng M, Jun F, Le Q, Tingting T. Serum miRNA expression and correlation with clinical characteristics in acute kidney injury. Int. J. Clin. Exp. Pathol. 2017; 10 (8): 8721– 8726.; Sui W, Dai Y, Huang Y, Lan H, Yan Q, Huang H. Microarray analysis of MicroRNA expression in acute rejection after renal transplantation. Transpl. Immunol. 2008; 19 (1): 81–85.; Betts G, Shankar S, Sherston S, Friend P, Wood KJ. Examination of serum miRNA levels in kidney transplant recipients with acute rejection. Transplantation. 2014; 97: e28–30.; Tao J, Yang X, Han Z, Lu P, Wang J, Liu X et al. Serum microRNA-99a helps detect acute rejection in renal transplantation. Transplant. Proc. 2015; 47: 1683–1687.; Anglicheau D, Sharma VK, Ding R, Hummel A, Snopkowski C, Dadhania D et al. MicroRNA expression profiles predictive of human renal allograft status. Proc. Natl. Acad. Sci. USA. 2009; 106 (13): 5330–5335.; Matz M, Fabritius K, Lorkowski C, Dürr M, Gaedeke J, Durek P. Identification of T Cell- Mediated Vascular Rejection After Kidney Transplantation by the Combined Measurement of 5 Specific MicroRNAs in Blood Transplantation. 2016; 100 (4): 898–907.; Liu X, Dong C, Jiang Z, Wu WK, Chan MT, Zhang J et al. MicroRNA-10b downregulation mediates acute rejection of renal allografts by derepressing BCL2L11. Exp. Cell Res. 2015; 333 (1): 155–163.; Misra MK, Pandey SK, Kapoor R, Sharma RK, Agrawal S. Genetic variants of MicroRNA-related genes insusceptibility and prognosis of end-stage renal disease and renal allograft outcome among north Indians. Pharmacogenetics and Genomics. 2014; 24 (9): 442–450.; Bijkerk R, Florijn BW, Khairoun M, Duijs JMGJ, Ocak G, de Vries APJ et al. Acute rejection after kidney transplantation associates with circulating microRNAs and vascular injury. Transplant. Direct. 2017; 3 (7): e174.; Scian MJ, Maluf DG, David KG, Archer KJ, Suh JL, Wolen AR et al. MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am. J. Transplant. 2011; 11 (10): 2110–2122.; Glowacki F, Savary G, Gnemmi V, Buob D, Van der Hauwaert C, Lo-Guidice JM et al. Increased circulating miR-21 levels are associated with kidney fibrosis. PLoS One. 2013; 8 (2): e58014.; Danger R, Paul C, Giral M, Lavault A, Foucher Y, Degauque N. et al. Expression of miR-142-5p in Peripheral Blood Mononuclear Cells from Renal Transplant Patients with Chronic Antibody-Mediated Rejection. PLoS One. 2013; 8 (4): e60702.; Chen J, Zmijewska A, Zhi D, Mannon R B. Cyclosporine-mediated allograft fibrosis is associated with micro- RNA-21 through AKT signaling. Transpl. Int. 2015; 28: 232–245.; Yuan J, Benway CJ, Bagley J, Iacomini J. Micro-RNA-494 promotes cyclosporine- induced nephrotoxicity and epithelial to mesenchymal transition by inhibiting PTEN. Am. J. Transplant. 2015; 15: 1682–1691.; Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, Anderson B. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One. 2009; 4: e 6229.; Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K et al. Detection of elevated levels of tumour associated microRNAs in serum of patients with diffuse large b-cell lymphoma. Br. J. Haematol. 2008; 141: 672–675.; Tam S, de Borja R, Tsao MS, McPherson JD. Robust global microrna expression profiling using next-generation sequencing technologies. Lab. Invest. 2014; 94: 350– 358.; Chen Y, Gelfond JA, McManus LM, Shireman PK. Reproducibility of quantitative RT- PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics. 2009; 10: 407.; Linsen SE, de Wit E, Janssens G, Heater S, Chapman L, Parkin RK et al. Limitations and possibilities of small RNA digital gene expression profiling. Nat. Methods. 2009; 6: 474–476.; Sablok G, Milev I, Minkov G, Minkov I, Varotto C, Yahubyan G et al. Isomirex: Web- based identification of microRNAs, isomir variations and differential expression using next generation sequencing datasets. FEBS Lett. 2013; 587: 2629–2634.; Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005; 33: e179.; https://journal.transpl.ru/vtio/article/view/917

الاتاحة: https://journal.transpl.ru/vtio/article/view/917
https://doi.org/10.15825/1995-1191-2018-3-87-94

المؤلفون: N. Shmarina V., R. Storozhev V., O. Rzhevskaya N., N. Zagorodnikova V., A. Pinchuk V., Н. Шмарина В., Р. Сторожев В., О. Ржевская Н., Н. Загородникова В., А. Пинчук В.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 1-2 (2012); 15-19 ; Трансплантология; № 1-2 (2012); 15-19 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2012-0-1-2

مصطلحات موضوعية: liver transplantation, acute rejection, трансплантация почки, острое отторжение

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/374/435; Бирюкова, Л.С. Стратегия трансплантации почки и режимы иммуносупрессии / Л.С. Бирюкова // Нефрология и диализ. – 1999. – Т. 1, № 2–3.; Иммуносупрессия при трансплантации солидных органов / под ред. С.В. Готье. – М.: [Б. и.], 2011. – С. 47.; Мофетиламикофенолат в профилактике острого отторжения почечного трансплантата и лечении хронической трансплантационной нефропатии / Е.О. Щербакова [и др.] // Нефрология и диализ. – 2004. – Т. 6, № 1.; Conversionfrom Cyclosporine to Tacrolimus Improves Quality-of-Life Indices, Renal Graft Function and Cardiovascular Risk Profile / M.A. Artz [et al.] // Am. J. Transplant. – 2004. – 4 (6).; Advances in immunosuppression for renal transplantation / A. Durrbach [et al.] // Nat. Rev. Nephrol. – 2010. – Mar., 6 (3). – P. 160–167.; Helal, I. Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation / I. Helal, L. Chan // Transplant. Proc. – 2011. – 43 (2). – P. 472–427.; Current immunosuppressive treatment after kidney transplantation / M. Kho [et al.] // Expert Opin Pharmacother. – 2011. – Jun., 12 (8). – P. 1217–1231.; A comparison of tacrolimus (Fk506) and cyclosporine for immunosuppression after cadaveric renal transplantation / J.D. Pirsch [et al.] // Clin. Transplant. – 1997. – Vol. 63, I. 7. – P. 977–983.; Ponticelli, C. Present and future of immunosuppressive therapy in kidney transplantation / C. Ponticelli // Transplant. Proc. – 2011. – Jul-Aug., 43 (6). – P. 2439–2440.; Tacrolimus versus cyclosporine for early steroid withdrawal after renal transplantation / S. Sandrini // J. Nephrol. – 2012. – Vol. 25 (1). – P. 43–49.; https://www.jtransplantologiya.ru/jour/article/view/374

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/374
https://doi.org/10.23873/2074-0506-2012-0-1-2-15-19

المؤلفون: M. Sh. Khubutiya, V. A. Gulyaev, V. B. Khvatov, V. L. Lemenev, S. A. Kabanova, M. S. Novruzbekov, K. N. Lutsyk, O. D. Olisov, S. V. Zhuravel', G. V. Bulava, D. Kh. Tsurova, N. V. Borovkova, А. S. Mironov, L. N. Zimina, М. Ш. Хубутия, В. А. Гуляев, В. Б. Хватов, В. Л. Леменёв, С. А. Кабанова, М. С. Новрузбеков, К. Н. Луцык, О. Д. Олисов, С. В. Журавель, Г. В. Булава, Д. Х. Цурова, Н. В. Боровкова, А. С. Миронов, Л. Н. Зимина

المصدر: Transplantologiya. The Russian Journal of Transplantation; Том 9, № 3 (2017); 211-225 ; Трансплантология; Том 9, № 3 (2017); 211-225 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2017-9-3

مصطلحات موضوعية: иммунологическая толерантность, acute rejection, immunological tolerance, острое отторжение

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/179/223; https://www.jtransplantologiya.ru/jour/article/view/179/256; Raychaudhuri S.P., Kundu-Raychaudhuri S., Tamura K., et al. FR255734, a humanized, Fc-Silent, Anti-CD28 antibody, improves psoriasis in the SCID mouse-psoriasis xenograft model. J. Invest. Dermatol. 2008;128:1969–1976. PMID:18337836 DOI:10.1038/jid.2008.38; Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy. 2003;5(6):485–489. PMID:14660044 DOI:10.1080/14653240310003611; Owen R.D. Immunogenetic consequences of vascular anastomoses between bovine twins. Science. 1945;102:400–401. DOI:10.1126/science.102.2651.400 PMID:17755278; Demikhov V.P. A new and simpler variant of heart-lung preparation of a warm-blooded animal. Bull. Eksp. Biol. Med. 1950; (7): 21–27.; Hašek M., Puza A. On the induction of immunological tolerance in adult recipients. Folia Biol (Praha). 1962;8:55–57. PMID:13905162; Marsh S.G., Albert E.D., Bodmer W.F., et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75(4):291–455. PMID:20356336 DOI:10.1111/j.1399-0039.2010.01466.x; Medawar P.B. A second study of the behaviour and fate of skin homografts in rabbits A Report to the War Wounds Committee of the Medical Research Council. J. Anat. 1945;79(Pt 4):157–176.4. PMID:17104981; Хубутия М.Ш. (ред.) Трансплантация органов и тканей в многопрофильном научном центре. М.: АирАрт, 2011. 424 с.; Ruiz P., Maldonado P., Hidalgo Y., et al. Transplant Tolerance: New Insights and Strategies for Long-Term Allograft Acceptance. Clin. Dev. Immu- nol. 2013;2013:210506. PMID:23762087 DOI:10.1155/2013/210506; Манько В.М., Девришов Д.А. Вете- ринарная иммунология. Фундаменталь- ные основы. М.: Агровет, 2011. 752 с.; Oluwole S.F., Oluwole O.O., Adey- eri A.O., DePaz H.A. New strategies in immune tolerance induction. Cell Bio- chem. Biophys. 2004;40(3 Suppl.):27–48. PMID:15289641; Nijagal A., Derderian C., Le T., et al. Direct and indirect antigen presentation lead to deletion of donor-specific T cells after in utero hematopoietic cell transplantation in mice. Blood. 2013;121(22):4595–4602. PMID:23610372 DOI:10.1182/blood-2012-10-463174; Voll R.E., Herrmann M., Roth E.A., et al. Immunosuppressive effects of apoptotic cells. Nature. 1997;390(6658):350–351. PMID:9389474 DOI:10.1038/37022; Williams C.A., Harry R.A., McLeod J.D. Apoptotic cells induce dendritic cell-mediated suppression via interferon--induced IDO. Immunology. 2008;124(1):89–101. PMID:18067553 DOI:10.1111/j.1365-2567.2007.02743.x; Ezzelarab M., Thomson A.W. Tolerogenic dendritic cells and their role in transplantation. Semin. Immunol. 2011;23(4):252–263. PMID:21741270 DOI:10.1016/j.smim.2011.06.007; Hu J., Wan Y. Tolerogenic dendritic cells and their potential applications. Immunology. 2011;132(3):307–314. PMID:21208205 DOI:10.1111/j.1365-2567.2010.03396.x; Lewis K.L., Reizis B. Dendritic Cells: Arbiters of Immunity and Immunological Tolerance. Cold Spring Harb. Perspect. Biol. 2012;4(8):a007401. PMCID:PMC3405856 DOI:10.1101/cshperspect.a007401; Монастырская Е.А., Лямина С.В., Малышев И.Ю. М1 и М2 фенотипы активированных макрофагов и их роль в иммунном ответе и патологии. Патогенез. 2008;6(4):31–39.; Sutterwala F.S., Noel G.J., Salgame P., Mosser D.M. Reversal of proinflammatory responses by ligating the macrophage Fc receptor type I. J. Exp. Med. 1998;188(1):217–222. PMID:9653099; Lafferty K.J., Prowse S.J., Simeonovic C.J., Warren H.S. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu. Rev. Immunol. 1983;1:143–173. PMID:6443557 DOI:10.1146/annurev.iy.01.040183.001043; Bretscher P., Cohn M. A theory of self-nonself discrimination: paralysis and induction involve the recognition of one and two determinants on an antigen, respectively. Science. 1970;169:1042–1049. PMID:4194660; Lassila O., Vainio O., Matzinger P. Can B cells turn on virgin T cells? Nature. 1988;334:253–255. PMID:2969460 DOI:10.1038/334253a0; Ashwell J.D., Jenkins M.K., Schwartz R.H. Effect of gamma radiation on resting B lymphocytes. II. Functional characterization of the antigen-presentation defect. J. Immunol. 1988;141(8):2536–2254. PMID:2844902; Fuchs E.J., Matzinger P. B cells turn off virgin but not memory T cells. Science. 1992;258:1156–1159. PMID:1439825; Billingham R.E., Brent L., Medawar PB. Actively acquired tolerance of foreign cells. Nature. 1953;172:603–606. PMID:13099277; Ranheim E.A., Kipps T.J. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 1993;177(4):925–935. PMID:7681471; Фрейдлин И.С. Регуляторные Т-клетки: происхождение и функции. Медицинская иммунология. 2005;7(4):347–354 DOI:10.15789/1563-0625-2005-4-347-354; Marino J., Paster J., Benichou G. Allorecognition by T Lymphocytes and Allograft Rejection. Front. Immunol. 2016;7:582. PMID:28018349 DOI:10.3389/fimmu.2016.00582.eCollection 2016; Vincenti F., Dritselis A., Kirkpatrick P. Belatacept. Nat. Rev. Drug. Discov. 2011;10(9):655–656. PMID:21878974 DOI:10.1038/nrd3536; Cohen J.B., Eddinger K.C., Forde K.A., et al. Belatacept Compared to Tacrolimus for Kidney Transplantation: A Propensity Score Matched Cohort Study. Transplantation. 2016; [Epub ahead of print] PMID:27941427 DOI:10.1097/TP.0000000000001589; Goring S.M., Levy A.R., Ghement I., et al. A network meta-analysis of the efficacy of belatacept, cyclosporine and tacrolimus for immunosuppression therapy in adult renal transplant recipients. Curr. Med. Res. Opin. 2014;30(8):1473–1487. PMID:24628478 DOI:10.1185/03007995.2014.898140; Durrbach A., Pestana J.M., Florman S., et al. Long-Term outcomes in Belatacept Versus Cyclosporine-Treated recipients of extended criteria donor kidneys: final results from BENEFIT-EXT, a Phase III Randomized Study. Am. J. Transplant. 2016;16(11):3192–3201. PMID:27130868 DOI:10.1111/ajt.13830; Masson P., Henderson L., Chapman J.R., et al. Belatacept for kidney transplant recipients. Cochrane Database Syst. Rev. 2014;(11):CD010699. PMID:25416857 DOI:10.1002/14651858.CD010699.pub2; Hu M., Wang C., Zhang G.Y., et al. Infiltrating Foxp3(+) regulatory T cells from spontaneously tolerant kidney allografts demonstrate donor-specific tolerance. Am. J. Transplant. 2013;13(11):2819–2830. PMID:24102948 doi:10.1111/ajt.12445; Shalev I., Selzner N., Shyu W., et al. Role of regulatory T cells in the promotion of transplant tolerance. Liver Transpl. 2012;18(7):761–770. PMID:22523007 DOI:10.1002/lt.23458; Juvet S.C., Whatcott A.G., Bushell A.R., Wood K.J. Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning. Am. J. Transplant. 2014;14(4):750–763. PMID:24592900 DOI:10.1111/ajt.12647; Singh K., Stempora L., Donald Harvey R., et al. Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. Am. J. Transplant. 2014;14(12):2691–2703. PMID:25359003 DOI:10.1111/ajt.12934; Fisher S.A., Lamikanra A., Dorée C. Increased regulatory T cell graft content is associated with improved outcome in haematopoietic stem cell transplantation: a systematic review. Br. J. Haematol. 2017;176(3):448–463. PMID:28094847 DOI:10.1111/bjh.14433; Alessandrini A., Turka L.A. FOXP3-Positive Regulatory T Cells and Kidney Allograft Tolerance. Am J Kidney Dis. 2017;69(5):667–674. PM-ID:28049555 DOI:10.1053/j.ajkd.2016.10.027; Noyan F., Zimmermann K., Hardtke-Wolenski M. Prevention of allograft rejection by use of regulatory T cells with a MHC-specific chimeric antigen receptor. Am J Transplant. 2017;17(4):917–930. PMID:27997080 DOI:10.1111/ajt.14175; Abe Y., Urakami H., Ostanin D., et al. Induction of Foxp3-Expressing Regulatory T-Cells by Donor Blood Transfusion Is Required for Tolerance to Rat Liver Allografts. PLoS One. 2009;4(11):e7840. PMID:19956764 DOI:10.1371/journal.pone.0007840; Dummer C.D., Carpio V.N., Gonçalves L.F., et al. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance. Transpl. Immunol. 2012;26(1):1–10. DOI:10.1016/j.trim.2011.08.009; Zhang L.F., Xia C.Q. Ex vivo expansion of regulatory T cells for clinical applications against graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. Chin. Med. J. (Engl). 2013;126(23):4575–4582. PMID:24286428; Tang Q. Pharmacokinetics of Therapeutic Tregs. Am. J. Transpl. 2014;14(12):2679–2680. doi:10.1111/ajt.12933. PMID:25358900; Pilat N., Klaus C., Gattringer M., et al. Therapeutic efficacy of polyclonal Tregs does not require rapamycin in a low-dose irradiation bone marrow transplantation model. Transplantation. 2011;92(3):280–288. PMID:21697774 DOI:10.1097/TP.0b013e3182241133; Vanikar A.V., Trivedi H.L., Feroze A., et al. Effect of co-transplantation of mesenchymal stem cells and hematopoietic stem cells as compared to hematopoietic stem cell transplantation alone in renal transplantation to achieve donor hyporesponsiveness. Int. Urol. Nephrol. 2011;43(1):225–232. PMID:20084457 DOI:10.1007/s11255-009-9659-1; Miyairi S., Hirai T., Ishii R., et al. Donor bone marrow cells are essential for iNKT cell-mediated Foxp3+ Treg cell expansion in a murine model of transplantation tolerance. Eur. J. Immunol. 2017;47(4):734–742 PMID:28127757 DOI:10.1002/eji.201646670; Hsu W.T., Lin C.H., Chiang B.L., et al. Prostaglandin E2 potentiates mesenchymal stem cell-induced IL-10+IFN-+CD4+ regulatory T cells to control transplant arteriosclerosis. J. Immunol. 2013;190(5):2372–2380. PMID:23359497 DOI:10.4049/jimmunol.1202996; Crop M.J., Baan C.C., Korevaar S.S., et al. Donor-derived mesen-chymal stem cells suppress alloreactivity of kidney transplant patients. Transplantation. 2009;87(6):896–906. PMID:19300194 DOI:10.1097/TP.0b013e31819b3d72; Peng Y., Ke M., Xu L., et al. Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: A Clinical Pilot Study. Transplantation. 2013;95(1):161–168. PMID:23263506 DOI:10.1097/TP.0b013e3182754c53; Tan J., Wu W., Xu X., et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA. 2012;307(11):1169–1177. PMID:22436957 DOI:10.1001/jama.2012.316; Popp F.C., Renner P., Eggenhofer E., et al. Dahlke mesenchymal stem cells as immunomodulators after liver transplantation. Liver Transpl. 2009;15;1192–1198. PMID:19790154 DOI:10.1002/lt.21862; Xu G., Zhang L., Ren G., et al. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Cell. Res. 2007;17:240–248. PMID:17325691 DOI:10.1038/cr.2007.4; Aggarwal S., Pittenger M.F. Human mesenchymal stem cells mod-ulate allogeneic immune cell responses. Blood. 2005;105(4):1815–1822. PMID:15494428 DOI:10.1182/blood-2004-04-1559; Ryan J.M., Barry F., Murphy J.M., Mahon B.P. Interferongamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin. Exp. Immunol. 2007;149(2):353–363. PMID:17521318 DOI:10.1111/j.1365-2249.2007.03422.x; Popp F.C., Eggenhofer E., Renner P., et al. Mesenchymal stem cells can induce longterm acceptance of solid organ allografts in synergy with lowdose mycophenolate. Transpl. Immunol. 2008;20(1–2):55–60. PMID:18762258 DOI:10.1016/j.trim.2008.08.004; Kishimoto K., Yuan X., Auchincloss H.Jr., et al. Mechanism of action of donor-specific transfusion in inducing tolerance: role of donor MHC molecules, donor co-stimulatory molecules, and indirect antigen presentation. J. Am. Soc. Nephrol. 2004;15:2423–2428. PMID:15339991 DOI:10.1097/01.ASN.0000137883.20961.2D; Dave S.D., Vanikar A., Trivedi H.L., et al. Stem cells versus donor specific transfusions for tolerance induction in living donor renal transplantation: a single-center experience. Transplantation. 2013;95(1):155–160. PMID:23263505 DOI:10.1097/TP.0b013e3182752bcc; Юдин С.С. Вопросы военно-полевой хирургии и переливание посмертной крови. М.: Медгиз, 1960: 309–393.; Никулина В.П., Гуляев В.А., Годков М.А., Кобзева Е.Н. Иммунологические аспекты использования эритроцитарной массы донора органа при трансплантации печени. В сб.: Хубутия М.Ш. (ред.) Актуальные вопросы трансплантации органов: материалы гор. науч.-практ. конф. М.: Триада, 2008: 93–95.; Khubutia M., Zhuravel S., Gulyaev V., et al. Using of Blood from Cadaveric Donor in Orthotopic liver Transplantation. Bull. Georg. Nat. Acad. Sci. 2014;8(3):108–115.; https://www.jtransplantologiya.ru/jour/article/view/179

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/179
https://doi.org/10.23873/2074-0506-2017-9-3-211-225

المؤلفون: R. Sh. Saitgareev, V. M. Zakharevich, A. M. Golts, T. A. Khalilulin, D. V. Borisov, Р. Ш. Саитгареев, В. М. Захаревич, А. М. Гольц, Т. А. Халилулин, Д. В. Борисов

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 18, № 2 (2016); 142-151 ; Вестник трансплантологии и искусственных органов; Том 18, № 2 (2016); 142-151 ; 2412-6160 ; 1995-1191 ; 10.15825/1995-1191-2016-2

مصطلحات موضوعية: острое отторжение, heart retransplantation, cardiac allograft vasculopathy, acute rejection, ретрансплантация сердца, васкулопатия сердечного трансплантата

وصف الملف: application/pdf

Relation: https://journal.transpl.ru/vtio/article/view/649/550; Lund LH, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Goldfarb S et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report-2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant. 2015 Oct; 34 (10): 1244–1254. doi:10.1016/j.healun.2015.08. 003. Epub 2015 Aug 28.; Atluri P, Hiesinger W, Gorman RC, Pochettino A, Jessup M, Acker MA et al. Cardiac retransplantation is an efficacious therapy for primary cardiac allograft failure. J Cardiothorac Surg. 2008 May 7; 3: 26. doi:10.1186/1749-8090-3-26.; Clerkin KJ, Thomas SS, Haythe J, Schulze PC, Farr M, Takayama H et al. Mechanical circulatory support as a bridge to cardiac retransplantation: a single center experience. J Heart Lung Transplant. 2015 Feb; 34 (2): 161–166. doi:10.1016/j.healun.2014.09.033. Epub 2014 Sep 28.; Kalya A, Jaroszewski D, Pajaro O, Scott R, Gopalan R, Kasper D, Arabia F. Role of total artificial heart in the management of heart transplant rejection and retransplantation: case report and review. Clin Transplant. 2013 Jul-Aug; 27 (4): E348–50. doi:10.1111/ctr.12146. Epub 2013 May 31.; Ricci M, Panos AL, Andreopoulos FM, Rusconi P, Rosenkranz E, Barron M, Pham SM. Successful use of a custom-made paracorporeal total artificial heart as a bridge to retransplantation in adult and adolescent patients. J Heart Lung Transplant. 2009 Aug; 28 (8): 834–837. doi:10.1016/j.healun.2009.05.008.; Lamich R, Ballester M, Martí V, Brossa V, Aymat R, Carrió I et al. Efficacy of augmented immunosuppressive therapy for early vasculopathy in heart transplantation. J Am Coll Cardiol. 1998 Aug; 32 (2): 413–419.; Mancini D, Pinney S, Burkhoff D, LaManca J, Itescu S, Burke E et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation. 2003 Jul 8; 108 (1): 48–53.; Raichlin E, Bae JH, Khalpey Z, Edwards BS, Kremers WK, Clavell AL et al. Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation. 2007 Dec 4; 116 (23): 2726–2733.; Swan JW, Norell M, Yacoub M, Mitchell AG, Ilsley C. Coronary angioplasty in cardiac transplant recipients. Eur Heart J. 1993; 14: 65–70. doi:10.1093/eurheartj/14.1.65.; Christensen BV, Meyer SM, Iacarella CL, Kubo SH, Wilson RF. Coronary angioplasty in heart transplant recipients: a quantitative angiographic long-term follow-up study. J Heart Lung Transplant.1994; 13: 212–220.; Jain SP, Ventura HO, Ramee SR, Collins TJ, Isner JM, White CJ. Directional coronary atherectomy in heart transplant recipients. J Heart Lung Transplant. 1993; 12: 819–823.; Strikwerda S, Umans V, van der Linden MM, van Suylen RJ, Balk AH, de Feyter PJ et al. Percutaneous directional atherectomy for discrete coronary lesions in cardiac transplant patients. Am Heart J. 1992; 123: 1686–1690. doi:10.1016/0002-8703(92)90824-F.; Musci M, Loebe M, Wellnhofer E, Meyer R, Pasic M, Hummel M et al. Coronary angioplasty, bypass surgery, and retransplantation in cardiac transplant patients with graft coronary disease. Thorac Cardiovasc Surg. 1998; 46: 268–274. doi:10.1055/s-2007-1010237.; Halle AA, III, DiSciascio G, Massin EK, Wilson RF, Johnson MR, Sullivan HJ et al. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol. 1995; 26: 120–128. doi:10.1016/0735-1097(95)00124-I.; Wong PM, Piamsomboon C, Mathur A, Chastain HD, II, Singh DJ, Liu MW et al. Efficacy of coronary stenting in the management of cardiac allograft vasculopathy. Am J Cardiol. 1998; 82: 239–241. doi:10.1016/S00029149(98)00295-1.; Jain SP, Ramee SR, White CJ, Mehra MR, Ventura HO, Zhang S et al. Coronary stenting in cardiac allograft vasculopathy. J Am Coll Cardiol. 1998; 32: 1636–1640. doi:10.1016/S0735-1097(98)00432-X.; Evans RW, Manninen DL, Dong FB, McLynne DA. Is retransplantation cost effective? Transplant Proc. 1993; 25 (1 Pt 2): 1694–1696.; Copeland G, Griepp RB, Bieber CP et al. Successful retransplantation of the human heart. J Thorac Cardiovasc Surg. 1977; 73: 242–247.; Odim J, Banerji A, Bahrami S, Laks H. Is third-time heart retransplantation justifiable? Transplant Proc. 2006; 38 (5): 1516–1519.; Copeland H, Coelho-Anderson R, Mineburg N, McCarthy M, Copeland JG. Elective cardiac retransplantation: a viable option that can be repeated. J Thorac Cardiovasc Surg. 2011 Mar; 141 (3): 822–827. doi:10.1016/j. jtcvs.2010.11.027. Epub 2011 Jan 26.; Copeland H, Gustafson M, Coelho-Anderson R, Mineburg N, Friedman M, Copeland JG. Thirdand fourthtime cardiac retransplantation: an option in selected patients. J Heart Lung Transplant. 2012 Mar; 31 (3): 336–337. doi:10.1016/j.healun.2011.12.003.; Copeland H, Gustafson M, Coelho-Anderson R, Mineburg N, Friedman M, Copeland JG. Fourth time cardiac retransplantation. World J Pediatr Congenit Heart Surg. 2014 Jan 1; 5 (1): 88–90. doi:10.1177/2150135113507291.; Chou NK, Chi NH, Chen YS, Yu HY, Lee CM, Huang SC et al. Heart retransplantation for heart allograft failure in Chinese heart transplant recipients: NTUH experience. Transplant Proc. 2006; 38: 2147–2148.; Michler RE, McLaughlin MJ, Chen JM, Geimen R, Schenkel F, Smith CR et al. Clinical experience with cardiac retransplantation. J Thorac Cardiovasc Surg. 1993; 106: 622–629. Discussion 629–631.; Radovancevic B, McGiffin DC, Kobashigawa JA, Cintron GB, Mullen GM, Pitts DE et al. Retransplantation in 7,290 primary transplant patients: a 10-year multi-institutional study. J Heart Lung Transplant. 2003; 22: 862–868.; Smith JA, Ribakove GH, Hunt SA, Miller J, Stinson EB, Oyer PE et al. Heart retransplantation: the 25-year experience at a single institution. J Heart Lung Transplant. 1995; 14: 832–839.; Srivastava R, Keck BM, Bennett LE, Hosenpud JD. The results of cardiac retransplantation: an analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. Transplantation. 2000; 70: 606–612.; Shuhaiber JH, Kim JB, Hur K, Gibbons RD, Nemeh HW, Schwartz JP, Bakhos M. Comparison of survival in primary and repeat heart transplantation from 1987 through 2004 in the United States. Ann Thorac Surg. 2007; 83: 2135–2141.; Schnetzler B, Pavie A, Dorent R, Camproux AC, Leger P, Delcourt A, Gandjbakhch I. Heart retransplantation: a 23-year singlecenter clinical experience. Ann Thorac Surg. 1998; 65: 978–983.; Topkara VK, Dang NC, John R, Cheema FH, Barbato R, Cavallo M et al. A decade experience of cardiac retransplantation in adult recipients. J Heart Lung Transplant. 2005; 24: 1745–1750.; Johnson MR, Aaronson KD, Canter CE et al. Heart retransplantation. Am J Transplant. 2007; 7: 2075–2081.; John R, Chen JM, Weinberg A et al. Long-term survival after cardiac retransplantation: a twenty-year singlecenter experience. J Thorac Cardiovasc Surg. 1999; 117: 543–555.; Tsao L, Uriel N, Leitz K, Naka Y, Mancini D. Higher rate of comorbidities after cardiac retransplantation contributes to decreased survival. J Heart Lung Transplant. 2009; 28: 1072–1074.; Iribarne A, Hong KN, Easterwood R et al. Should heart transplant recipients with early graft failure be considered for retransplantation? Ann Thorac Surg. 2011; 92: 923–928.; Kilic A, Weiss ES, Arnaoutakis GJ, George TJ, Conte JV, Shah AS, Yuh DD. Identifying recipients at high risk for graft failure after heart retransplantation. Ann Thorac Surg. 2012 Mar; 93 (3): 712–716. doi:10.1016/j.athoracsur.2011.10.065. Epub 2012 Jan 5.; Saito A, Novick RJ, Kiaii B, McKenzie FN, Quantz M, Pfl ugfelder P et al. Early and late outcomes after cardiac retransplantation. Can J Surg. 2013 Feb; 56 (1): 21–26. doi:10.1503/cjs.012511.; Karamlou T, Hirsch J, Welke K, Ohye RG, Bove EL, Devaney EJ, Gajarski RJ. A United Network for Organ Sharing analysis of heart transplantation in adults with congenital heart disease:outcomes and factors associated with mortality and retransplantation. J Thorac Cardiovasc Surg. 2010 Jul; 140 (1): 161–168. doi:10.1016/j. jtcvs.2010.03.036.; Lund LH, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI et al. International Society of Heart and Lung Transplantation. The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report – 2014; focus theme: retransplantation. J Heart Lung Transplant. 2014 Oct; 33 (10): 996–1008. doi:10.1016/ j.healun.2014.08.003. Epub 2014 Aug 14.; Yusen RD, Edwards LB, Kucheryavaya AY et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-first adult lung and heart – lung transplant report – 2014; Focus theme: Retransplantation. J Heart Lung Transplant. 2014; 33: 1009–1024.; Khan MS, Mery CM, Zafar F et al. Is mechanically bridging patients with a failing cardiac graft to retransplantation an effective therapy? Analysis of the United Network of Organ Sharing database. J Heart Lung Transplant. 2012; 31: 1192–1198.; Noirhomme P, d’Udekem Y, Jacquet L et al. Is mechanical circulatory support helpful before cardiac retransplantation? Cardiovasc Surg. 1997; 5: 584–587.; Schulze PC, Kitada S, Clerkin KJ, Jin Z, Mancini DM. Regional differences in recipient waitlist time and preand post-transplant mortality following the 2006 UNOS policy changes in the donor heart allocation algorithm. JACC Heart Fail. 2014; 2: 166–177.; Minev PA, El-Banayosy A, Minami K et al. Differential indication for mechanical circulatory support following heart transplantation. Intensive Care Med. 2001; 27: 1321–1327.; Saxena P, Marasco SF, McGiffin DC, Weintraub R, Bergin P, Konstantinov IE. Mechanical circulatory assist as a bridge to heart retransplantation in adolescents. J Card Surg. 2014 Sep; 29 (5): 752–754. doi:10.1111/ jocs.12412. Epub 2014 Jul 25.; Belli E, Leoni Moreno JC, Hosenpud J, Rawal B, Landolfo K. Preoperative risk factors predict survival following cardiac retransplantation: analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg. 2014 Jun; 147 (6): 1972–1977, 1977.e1. doi:10.1016/ j.jtcvs. 2014. 02. 013. Epub 2014 Feb 12.; Magee JC, Barr ML, Basadonna GP et al. Repeat organ transplantation in the United States, 1996–2005. Am J Transplant. 2007; 7 (Part 2): 1424–1433.; Ensley RD, Hunt S, Taylor DO et al. Predictors of survival after repeat heart transplantation. J Heart Lung Transplant. 1992; 11: S142–S158.; Karwande SV, Ensley RD, Renlund DG et al. Cardiac retransplantation: A viable option? Ann Thorac Surg. 1992; 54: 840–845.; Schlechta B, Kocher AA, Ehrlich M et al. Heart retransplantation: Institutional results of a series of 31 cases. Transplant Proc. 2001; 33: 2759–2761.; Tjang YS, Tenderich G, Hornik L, Wlost S, Bairaktaris A, Körfer R. Long-term experiences on cardiac retransplantation in adults. Eur J Cardiothorac Surg. 2007 Dec; 32 (6): 923–925. Epub 2007 Oct 29.; Goerler H, Simon A, Gohrbandt B, Hagl C, Oppelt P, Haverich A, Strueber M. Cardiac retransplantation: is it justified in times of critical donor organ shortage? Longterm single-center experience. Eur J Cardiothorac Surg. 2008 Dec; 34 (6): 1185–1190. doi:10.1016/ j.ejcts. 2008. 06.044. Epub 2008 Aug 9.; Pozzi M, d’Alessandro C, Fernandez F, Nguyen A, Pavie A, Leprince P et al. Who gets a second heart? A current picture of cardiac retransplantation. Transplant Proc. 2014 Jan-Feb; 46 (1): 202–207. doi:10.1016/j. transproceed. 2013.08.109.; Готье СВ, Шевченко АО, Кормер АЯ, Попцов ВН, Саитгареев РШ, Шумаков ДВ, Захаревич ВМ. Три десятилетия трансплантации сердца в ФНЦТИО имени академика В.И. Шумакова: отдаленные результаты. Вестник транплантологии и искусственных органов. 2015; 17 (2): 70–73. Got’e SV, Shevchenko AO, Kormer AYa, Popcov VN, Saitgareev RSh, Shumakov DV, Zaharevich VM. Tri desyatiletiya transplantacii serdca v FNCTIO imeni akademika V.I. Shumakova: otdalennye rezul’taty. Vestnik tranplantologii i iskusstvennyh organov. 2015; 17 (2): 70–73.; Саитгареев РШ, Попцов ВН, Шумаков ДВ, Захаревич ВМ, Акопов ГА, Гольц АМ и др. Опыт ретрансплантации сердца в ФНЦ трансплантологии и искусственных органов им. академика В.И. Шумакова Минздрава РФ. Бюллетень НЦССХ им. А.Н. Бакулева РАМН. 2013; 14 (6): 176. Saitgareev RSh, Popcov VN, Shumakov DV, Zaharevich VM, Akopov GA, Gol’c AM i dr. Opyt retransplantacii serdca v FNC transplantologii i iskusstvennyh organov im. akademika V.I. Shumakova Minzdrava RF. Byulleten’ NCSSKH im. A.N. Bakuleva RAMN. 2013; 14 (6): 176.; https://journal.transpl.ru/vtio/article/view/649

الاتاحة: https://journal.transpl.ru/vtio/article/view/649
https://doi.org/10.15825/1995-1191-2016-2-142-151

المؤلفون: Fedulkina V.A., Vatazin A.V., Kildyushevskiy A.V., Stolyarevich E.S., Kantaria R.O., Zulkarnayev A.B.

المصدر: Almanac of Clinical Medicine; No 28 (2013); 25-31 ; Альманах клинической медицины; No 28 (2013); 25-31 ; 2587-9294 ; 2072-0505 ; 10.18786/2072-0505-2013-28

مصطلحات موضوعية: allotransplantation of cadaveric kidneys, acute rejection of renal allograft, translational cellular immunotherapy, protocol renal allograft biopsy, аллотрансплантация трупной почки, острое отторжение почечного аллотрансплантата, трансляционная клеточная иммунотерапия, протокольная биопсия почечного аллотрансплантата

وصف الملف: application/pdf

Relation: https://almclinmed.ru/jour/article/view/5/7; https://almclinmed.ru/jour/article/view/5

الاتاحة: https://almclinmed.ru/jour/article/view/5
https://doi.org/10.18786/2072-0505-2013-28-25-31

المؤلفون: L.V. Shkalova, I.M. Iljinsky, O.M. Tsirulnikova, Л.В. Шкалова, И.М. Ильинский, О.М. Цирульникова

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 14, № 1 (2012); 95-105 ; Вестник трансплантологии и искусственных органов; Том 14, № 1 (2012); 95-105 ; 2412-6160 ; 1995-1191 ; 10.15825/1995-1191-2012-1

مصطلحات موضوعية: трансплантация печени, иммунитет, острое отторжение, морфология

وصف الملف: application/pdf

Relation: https://journal.transpl.ru/vtio/article/view/119/61; Аммосов А.А., Ахаладзе Д.Г., Хизроев Х.М. и др. Эффективность противовирусной терапии в профилактике развития цитомегаловирусной инфекции после трансплантации печени // Вестник трансплантологии и искусственных органов. Приложение. Материалы Всероссийской конференции «Инфекции в трансплантологии». М.–Тверь: Триада, 2009. Т. XI. С. 72.; Артамонов С.Д., Онищенко Н.А., Башкина Л.В. и др. Роль систем врожденного и адаптивного иммунитета в развитии деструктивного иммунного ответа организма на аллотрансплантат // Вестник трансплантологии и искусственных органов. 2010. Т. XII. No 3. С. 112–120.; Валюшева Т.П., Минов А.Ф., Щерба А.Е., Руммо О.О. Частота, структура и факторы риска бактериальных осложнений после ортотопической трансплантации печени // Вестник трансплантологии и искусственных органов. Приложение. Материалы Всероссийской конференции «Инфекции в трансплантологии». М.–Тверь: Триада, 2009. Т. XI. С. 73–74.; Габриэлян Н.И., Цирульникова О.М., Спирина Т.С. и др. Особенности микрофлоры зева и кишечника у пациентов до трансплантации печени // Вестник трансплантологии и искусственных органов. Приложение. Материалы Всероссийской конференции «Инфекции в трансплантологии». М.–Тверь: Триада, 2009. Т. XI. С. 77–78.; Готье С.В., Константинов Б.А., Цирульникова О.М. Трансплантация печени: Руководство для врачей. М.: Медицинское информационное агентство, 2008. 248 с.; Готье С.В., Мойсюк Я.Г., Ибрагимова О.С. Тенденции развития органного донорства и трансплантации в Российской Федерации в 2006–2008 гг. Сообщение І (по данным регистра Российского трансплантологического общества) // Вестник трансплантологии и искусственных органов. 2009. Т. XІ. No 3. С. 8–17.; Готье С.В., Цирульникова О.М. Ортотопическая трансплантация печени // Клиническая трансплантология; под ред. Б.А. Константинова. М.: Аир-Арт, 2004. С. 120–152.; Журавель С.В., Кузнецова Н.К., Чугунов А.О., Чжао А.В. Бактериальные осложнения в раннем послеоперационном периоде после трансплантации печени // Вестник трансплантологии и искусственных органов. Приложение. Материалы Всероссийской конференции «Инфекции в трансплан-; тологии». М.–Тверь: Триада, 2009. Т. XI. С. 81.; Корнилов М.Н., Милосердов И.А., Мойсюк Я.Г. Дренирование желчных протоков при ортотопической трансплантации печени // Вестник трансплантологии и искусственных органов. Приложение. Материалы V Всероссийского съезда трансплантологов.; М.–Тверь: Триада, 2010. Т. XII. С. 139.; Коротков С.В., Щерба А.Е., Руммо О.О. и др. Клиническое значение вариантной анатомии и типа артериальной реконструкции печеночной артерии при ортотопической трансплантации печени // Вестник трансплантологии и искусственных органов. Приложение. Материалы V Всероссийского съезда трансплантологов. М.–Тверь: Триада, 2010.; Т. XII. С. 136–137.; Минина М.Г., Гуляев В.А., Губарев К.К., Ахметшин Р.Б. Влияние некоторых донорских факторов на функцию трансплантированной печени // Актуальные вопросы трансплантации органов: Матери- алы городской научно-практической конференции. Тверь: Триада, 2008. С. 29–32.; Павлов Ч.С., Андрейцева О.И., Мусселиус С.Г. и др. Частота и факторы риска развития отторжения печени после трансплантации // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2003. Т. 13. No 1. С. 26–35.; Состояние органного донорства и трансплантации в России по итогам 2009 г. // Трансплантология 2009: итоги и перспективы / Под ред. С.В. Готье. Выпуск І. М.–Тверь: Триада, 2010. С. 8–20.; Хубутия М.Ш. Состояние и перспективы трансплантации органов в г. Москве // Актуальные вопросы трансплантации органов: Материалы городской науч.-практ. конференции. Тверь: Триада, 2008. С. 3–15.; Хубутия М.Ш., Андрейцева О.И., Журавель С.В. и др. Результаты трансплантации печени в НИИ СП им. Н.В. Склифосовского // Вестник трансплантологии и искусственных органов. 2010. Т. XII. No 2. С. 14–15.; Хубутия М.Ш., Чжао А.В., Шадрин К.Б. Послеоперационные осложнения у реципиентов при трансплантации печени: современные представления о патогенезе и основных направлениях профилактики и лечения // Вестник трансплантологии и искусственных органов. 2009. Т. XI. No 2. С. 60–66.; Цирульникова О.М. Печень в ранние сроки после ее обширных резекций и трансплантации: Автореф. дисс. . д-ра мед. наук. М., 2004. 37 с.; Чеклецова Е.В., Дегтярева А.В., Мухина Ю.Г. и др. Влияние исходного состояния потенциального реципиента на развитие инфекционных осложнений в раннем посттрансплантационном периоде // Вестник трансплантологии и искусственных органов. Приложение. Материалы Всероссийской конференции «Инфекции в трансплантологии». М.–Тверь: Триада, 2009. Т. XI. С. 82–83.; Чжао А.В., Джагарев К.Р., Чугунов А.О., Олисов О.Д. Билиарные осложнения после ортотопической трансплантации печени // Актуальные вопросы трансплантации органов: Материалы городской науч.-практ. конференции. Тверь: Триада, 2008. С. 70–71.; Шагидулин М.Ю., Габриэлян Н.И., Спирина Т.С. и др. Предупреждение инфекционных осложнений при трансплантации печени // Вестник трансплантологии и искусственных органов. Приложение. Материалы Всероссийской конференции «Инфекции в трансплантологии». М.–Тверь: Триада, 2009. Т. XI. С. 20–21.; Шадрин К.Б. Клинико-лабораторный мониторинг при трансплантации печени // Вестник трансплантологии и искусственных органов. Приложение. Материалы V Всероссийского съезда трансплантологов. М.–Тверь: Триада, 2010. Т. XII. С. 152.; Шумаков В.И. Трансплантология: Руководство. Тула: Медицина, 1995. С. 275–280.; Ярошенко Е.Б., Мойсюк Я.Г., Абдурахманов Д.Т. Значение ортотопической трансплантации печени в улучшении прогноза у больных циррозом печени различной этиологии // Вестник трансплантологии и искусственных органов. Приложение. Материалы V Всероссийского съезда трансплантологов. М.–Тверь: Триада, 2010. Т. XII. С. 140–142.; Abraham S.C., Freese D.K., Ishitani M.B. et al. Significance of central perivenulitis in pediatric liver transplantation // Am J. Surg. Patol. 2008. Vol. 32 (10). P. 1479–1488.; Andrade C.F., Waddell T.K., Keshavjee S. et al. Innate immunity and organ transplantation: The potential role of toll-like receptors // Am. J. Transplant. 2005. Vol. 5. P. 969–975.; Ben-Ari Z., Dhillon A.P., Moqbel R. et al. Monoclonal antibodies against eosinophils in liver allograft rejection // Liver Transpl. Surg. 1996. Vol. 2 (1). P. 46–51.; Blakolmer K., Jain A., Ruppert K. et al. Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging // Transplantation. 2000. Vol. 69 (11). P. 2330–2336.; Datta Gupta S., Hudson M., Burroughs A.K. et al. Grading of cellular rejection after orthotopic liver trans- plantation // Hepatology. 1995. Vol. 1. P. 46–57.; de Groen P.C., Kephart G.M., Gleich G.J., Ludwig J. The eosinophil is an effector cell of the immune response during hepatic allograft rejection // Hepatology. 1994. Vol. 20 (3). P. 654–662.; Demetris A.J., Belle S.H., Hart J. et al. Intraobserver and interobserver variation in the histopathological assessment of liver allograft rejection. The Liver Transplantation Database (LTD) Investigators [see comments] // Hepatology. 1991. Vol. 14 (5). P. 751–755.; Demetris A.J., Ruppert K., Dvorchik I. et al. Real-time monitoring of acute liver allograft rejection using the Banff schema // Transplantation. 2002. Vol. 74 (9). P. 1290–1296.; Demetris A.J., Seaberg E.C., Batts K.P. et al. Reliability and predictive value of the NIDDK liver transplant database nomenclature and grading system for cellular rejection of liver allografts // Hepatology. 1995. Vol. 21. P. 408–416.; Demetris A.J., Qian S.G., Sun H., Fung J.J. Liver allograft rejection: an overview of morphologic findings.; [Review] // Am J. Surg. Pathol. 1990. Vol. 1. P. 49–63.; Denys A., Chevallier P., Doenz F. et al. Interventional radiology in the management of complications after liver transplantation // Eur. Radiol. 2004. Vol. 14. P. 431–439.; Desmet V.J., Gerber M., Hoofnagle J.H. et al. Classification of chronic hepatitis: diagnosis, grading and staging // Hepatology. 1994. Vol. 19. P. 1513–1520.; Dixon L.R., Crawford J.M. Early histologic changes in fibrosing cholestatic hepatitis C // Liver Transpl. 2007.; Vol. 13 (2). P. 219–226.; Doherty D.S., O’Farrelly C. Lymphoid repertoires in healthy liver // Liver immunology; Gershwin M.E., Vierling J.M., Manns M.P.eds. Philadelphia:Hanley& Belfus. 2003. P. 31–46.; Dousset B., Hubscher S.G., Padbury R.T. et al. Acute liver allograft rejection-is treatment always necessary // Transplantation. 1993. Vol. 55. P. 529–534.; Hubscher S.G. Transplantation pathology // Semin Liver Dis. 2009. Vol. 29 (1). P. 74–90.; Hubscher S.G. Histological findings in liver allograft rejection – new insights into the pathogenesis of hepatocellular damage in liver allografts (comment) // Histopathol. 1991. Vol. 18. P. 377–383.; Hubscher S.G., Portmann B.C. Transplantation pathology // MacSween’s Pathology of the Liver, Burt A.D., Portmann B.C., Ferrel L.D., eds. 5th edn. Edinburgh: Churchill Livingstone. 2007. P. 815–879.; Hsieh C.L., Obara H., Ogura Y. et al. NK cells and transplantation // Transpl. Immunol. 2002. Vol. 9. P. 111–114.; Hsieh C.L., Ogura Y., Obara H. et al. Identification, cloning and characterization of a novel rat natural killer receptor, rNKp30: molecule expressed in liver allografts // Transplantation. 2004. Vol. 77. P. 121–128.; International Panel. Banff schema for grading liver allograft rejection: an international consensus document // Hepatology. 1997. Vol. 25. P. 658–663.; International Working Party. Terminology for hepatic allograft rejection // Hepatology. 1995. Vol. 22. P. 648–; Emond J.C., Renz J.F., Ferrell L.D. et al. Functional 654.; analysis of grafts from living donors. Implications for the treatment of older recipients // Ann Surg. 1996. Vol. 224 (4). P. 544–552.; Foster P.F., Sankary H.N., Hart M. et al. Blood and graft eosinophilia as predictor of rejection in human liver transplantation // Transplantation. 1989. Vol. 47. P. 72–74.; Golden-Mason L., O’Farrelly C. Having et al. Stem cells, haematopoiesis and lymphopoiesis in adult human liver // Immunol. Cell. Biol. 2002. Vol. 80. P. 45–51.; Goldstein D.R., Tesar B.M., Akira S., Lakkis F.G. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection // J. Clin. Invest. 2003. Vol. 111 (10). P. 1571–1578.; Ishak K.G., Baptista A., Bianchi L. et al. Histologic grading and stading of chronic hepatitis // J. Hepatol. 1995. Vol. 21. P. 696–699.; Jiang H., Chess L. Regulatory of Immune Responses by T-Cells // NEJM–2006. Vol. 11 (354). P. 1166–1176.; Kemnitz J., Gubernatis G., Bunzendahl H. et al. Criteria for the histopathologic classification of liver allo- graft rejection and their clinical significance // Transplant Proc. 1989. Vol. 21. P. 2208–2210.; Kemnitz J., Ringe B., Cohnert T.R. et al. Bile duct injury as part of diagnostic criteria for liver allograft rejec-; tion // Hum Pathol. 1989. Vol. 20. P. 132–143.; Kim I.K., Bedi D.S., Denecke C., Ge X., Tuliius S.G. Impact of Innate and Adaptive Immunity on Rejection and Tolerance // Transplantation. 2008. Vol. 86. P. 889–; Gomez-Manero N., Herrero J.I., Quiroga J. еt al. Impact of early acute rejection on outcome after liver 894.; transplantation // J. Hepatol; Postgraduated course and Abstracts of the 35th Annual Meeting of the European Association for the Study of the Liver. 2000. Rotterdam (The Netherlands): C 01/10.; Gouv A.S., van den Heuvel M.C., van den Berg A.P. et al. Significance of parenchemymal changes of acute cellular rejection in predicting chronic liver graft rejection // Transplantation. 2002. Vol. 73 (2). P. 243– 247.; Hassoun Z., Shah V., Lohse C.M. et al. Centrilobular necrosis after orthotopic liver transplantation: association with acute cellular rejection and impact on outcome // Liver Transpl. 2004. Vol. 10 (4). P. 480–487.; Höroldt B.S., Burattin M., Gunson B.K. et al. Does the Banff rejection activity index predict outcome in patients with early acute cellular rejection following liver transplantation? // Liver Transpl. 2006. Vol. 12 (7). P. 1144–1151.; Hubscher S.G. Diagnosis and grading of liver allograft rejection: a European perspective // Transplant Proc. 1996. Vol. 28. P. 504–507.; Knodell R.G., Ishak K.G., Black W.C. et al. Formulation and application of a numerical scoring system for assessing histologic activity in asymptomatic chronic active hepatitis // Hepatology. 1981. Vol. 1. P. 431–435.; Knolle P.A., Limmer A. Role and function of liver sinusoidal endothelial cells // Liver immunology. Gershwin M.E., Vierling J.M., Manns M.P. eds. Philadelphia: Hanley & Belfus. 2003. P. 59–73.; Krasinskas A.M., Demetris A.J., Poterucha J.J., Abraham S.C. The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers // Liver Transpl. 2008. Vol. 14 (5). P. 625–632.; Kwekkeboom J., Bruyneel B. et al. Are donor-livers with low expression of CD80 at the time of transplantation less susceptible to acute rejection? // J. Hepatol; Postgraduated course and Abstracs of the 35th Annual Meeting of the European Association for the Study of the Liver. 29 april–3 may 2000. Rotterdam (The Netherlands): P/C 01/49.; Lanier L.L. Natural killer cell receptor signaling // Curr. Opin. Immunol. 2003. Vol. 15. P. 308–314.; 65. LaRosa D.F., Rahman A.H., Turka L.A. The Innate Immune System in Allograft Rejection and Tolerance // The Journal of Immunology. 2007. Vol. 178. P. 7503– 7509.; Lau A.H., Thomson A.W. Dendritic cells and immune regulation in the liver // Gut. 2003. Vol. 52. P. 307–314.; Lemaitre B., Nicolas E., Michaut L. et al. The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults // Cell. 1996. Vol. 86. P. 973–983.; Lilly L.B., Ding J., Levy G.A. The immunology of hepatic allograft rejection // Transplantation of the liver. Maddrey W.C., Schiff E.R., Sorrell M. eds. Philadelphia: Lippincott Williams & Wilkins. 2001. P. 211–228.; Lo C.M. Complications and long-term outcome of living liver donors: a survey of 1,508 cases in five Asian centers // Transplantation. 2003. Vol. 15 (75). P. 12–15.; Lo C.M., Fan S.T., Liu C.L. et al. Lessons learned from one hundred right lobe living donor liver transplants //; Ann Surg. 2004. Vol. 240 (1). P. 151–158.; Lovell M.O., Speeg K.V., Halff G.A. et al. Acute hepatic allograft rejection: a comparison of patients with and without centrilobular alterations during first rejection episode // Liver Transpl. 2004. Vol. 10 (3). P. 369–373.; Ludwig J., Lefkowitch J. Histopathology of the liver following transplantation // Transplantation of the liver; Maddrey W., Schiff E., Sorrell M., eds. Philadelphia: Lippincott Williams & Wilkins. 2001. P. 229–250.; Makuuchi M., Sugawara Y. Technical progress in living donor liver transplantation for adults // H.P.B: the official of the international Hepato Pancreato Biliary Association. 2004. Vol. 6 (2). P. 95–98.; Martinez O.M., Ascher N.L., Ferrell L. et al. Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils // Transplantation. 1993. Vol. 55 (4). P. 909–918.; Martinez O.M., Rosen H.R. Basic concept in transplant immunology // Liver Transplantation. 2005. Vol. 11 (4). P. 370–381.; Matsuo K., Sekido H., Morioka D. et al. Surveillance of perioperative infections after adult living donor liver transplantation // Transplant Proc. 2004. Vol. 36 (8). P. 2299–2301.; Michaels P.J., Fishbein M.C., Colvin R.B. Humoral rejection of human organ transplants // Springer Semin Immunopathol. 2003. Vol. 25. P. 119–140.; Miller D.M., Thornley T.B., Greiner D.L., Rossini A.A. Viral Infection: A Potent Barrier to Transplantation Tolerance // Clin. Dev. Immunol. 2008. Vol. 2008. P. 742– 810.; Moeller J., Krukemeyer M.G., Morawietz L. et al. Molecular case report: IgVH analysis in acute humoral and cellular liver allograft rejection suggests a selected ac- cumulation of effector B cells and plasma cells // Vir- chows Arch. 2005. Vol. 446. P. 325–332.; Nagral A., Ben-Ari Z., Dhillon A.P., Burroughs A.K. Eosinophils in acute cellular rejection in liver allografts // Liver Transpl. Surg. 1998. Vol. 4 (5). P. 355–362.; Najafi an N., Albin M.J., Newell K.A. How Can We Measure Immunologic Tolerance in Humans // J. Am. Soc. Nephrol. 2006. Vol. 17. P. 2652–2663.; Neil D.A.H., Hübscher S.G. Current views on rejection pathology in liver transplantation // Transplant International. 2010. Vol. 23 (10). P. 971–983.; Neil D.A.H., Hübscher S.G. Histologic and biochemical changes during the evolution of chronic rejection of liver allografts Hepatology. 2002. Vol. 35 (3). P. 639–651.; O’Farrelly C. Immunoregulation in the liver and its extrahepatic relevance // J. Pediatr. Gastroenterol. Nutr. 2004. Vol. 39 (Suppl 3). P. 727–728.; Paterson H.M., Murphy T.J., Purcell E. et al. Injury primes the innate immune system for enhanced tolllike receptor reactivity // Immunol. 2003. Vol. 171. P. 1473–1483.; Regev A., Molina E., Moura R. et al. Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation // Liver Transpl. 2004. Vol. 10 (10). P. 1233–1239.; Sankary H., Foster P., Hart M. et al. An analysis of the determinants of hepatic allograft rejection using stepwise logistic regression // Transplantation. 1989. Vol. 47. P. 74–77.; Sawada T., Shimizu A., Kubota K. et al. Lobular damage caused by cellular and humoral immunity in liver allograft rejection // Clin. Transplant. 2005. Vol. 19. P. 110–114.; Sayegh M.H., Carpenter C.B. Transplantation 50 Years Later–Progress, Challenges, and Promises // NEJM. 2004. Vol. 26 (351). P. 2761–2766.; Schemedlng M., Dankof A., Krenn V. et al. C4d in acute rejection after liver transplantation – a valuable tool in differential diagnosis to hepatitis C recurrence // Am. J. Transplant. 2006. Vol. 6. P. 523–530.; Scheuer P.J. Classification of chronic viral hepatitis: a need for reassessment // J. Hepatol. 1991. Vol. 13. P. 372–374.; Selin L.K., Brehm M.A. Frontiers in Nephrology Heterologous Immunity, T-Cell Cross-Reactivity, and Alloreactivity // J. Am. Soc. Nephrol. 2007. Vol. 18. P. 2268–2277.; Shaked A., Ghobrial R.M., Merion R.M. et al. Incidence and severity of acute cellular rejection in recipi- ents undergoing adult living donor or deceased donor liver transplantation // Am. J. Transplant. 2009. Vol. 9. P. 301–308.; Snover D.C., Freese D.K., Sharp H.L. et al. Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection // Am. J. Surg. Pathol. 1987. Vol. 11 (1). P. 1–10.; Snover D.C., Sibley R.K., Freese D.K. Orthotopic liver transplantation: a pathologic study of 63 serial liver biopsies from 17 patients with specific reference to the diagnostic features and natural history of rejection // Hepatology. 1984. Vol. 4. P. 1212–1222.; Sun Z., Wada T., Maemura K. et al. Hepatic allograftderived Kupffer cells regulate T-cell response in rats // Liver Transpl. 2003. Vol. 9. P. 489–497.; Tippner C., Nashan B., Hoshino K. et al. Clinical and subclinical acute rejection early after liver transplantation: contributing factors and relevance for the long-term course // Transplantation. 2001. Vol. 72 (6). P. 1122–1128.; Uchiyama H., Hashimoto K., Hiroshige S. et al. Hepatic artery reconstruction in living-donor liver transplantation: a review of its techniques and complications // Surgery. 2002. Vol. 131 (Suppl 1). P. 200–204.; Valiante N. Natural killer cells and other variations on the theme of a cytotoxic lymphocyte. Hepatic Inflammation and Immunity Meeting, Galveston, TX, March 24. 2002.; Wertheimer A.W., Bakke A., Rosen H.R. Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease // Hepatology. 2004. Vol. 40. P. 335–345.; Yu Y.Y., Ji J., Zhou G.W., Shen B.Y. et al. Liver biopsy in evaluation of complications following liver transplantation // World J. Gastroenterology. 2004. Vol. 10 (11). P. 1678–1681.; Yu Y.Y., Shen B.Y., Zhou G.W. et al. Application of Banff schema in grading acute rejection following transplantation // Zhonghua Qiguan Yizhi Zazhi. 2003. Vol. 24. P. 76–77.; https://journal.transpl.ru/vtio/article/view/119

الاتاحة: https://journal.transpl.ru/vtio/article/view/119
https://doi.org/10.15825/1995-1191-2012-1-95-105

المؤلفون: A. V. Vatazin, I. A. Vasilenko, A. L. Valov, V. B. Metelin, E. E. Kruglov, A. Ya. Tsalman, А. В. Ватазин, И. А. Василенко, А. Л. Валов, В. Б. Метелин, Е. Е. Круглов, А. Я. Цалман

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 11, № 4 (2009); 18-25 ; Вестник трансплантологии и искусственных органов; Том 11, № 4 (2009); 18-25 ; 2412-6160 ; 1995-1191 ; 10.15825/1995-1191-2009-4

مصطلحات موضوعية: морфометрия, acute allograft rejection, lymphocytes, morphometry, острое отторжение, лимфоциты

وصف الملف: application/pdf

Relation: https://journal.transpl.ru/vtio/article/view/263/205; Ватазин А.В., Шумский В.И., Астахов П.В., Круг- лов Е.Е. Комплексное лечение хирургических забо- леваний у больных с терминальной стадией хрони- ческой почечной недостаточности. М.: МОНИКИ, 2002. 304 с.; Доровских Н.В. Ультразвуковая доплеровская диа- гностика сосудистых осложнений пересаженной почки // Вестник транспл. и искусств. органов. 2003. No 4. С. 41–45.; Жеребцов Ф.К., Гринев К.М., Енькина Т.Н. Состо- яние гемодинамики почечных трансплантатов от асистолических доноров и доноров со смертью моз- га в ближайшем послеоперационном периоде по данным доплерографического исследования // Вестник транспл. и искусств. органов. 2001. No 2. С. 31–35.; Руководство по трансплантации почки / Пер. с англ. под ред. Я.Г. Мойсюка. Третье издание. Тверь: Триада, 2004. 472 с.; Сандриков В.А., Садовников В.И. Клиническая физиология трансплантированной почки. М.: МАИК; «Наука/Интерпериодика», 2001. 288 с.; Труфакин А.В., Робинсон М.В. Иммуноморфология: вчера, сегодня, завтра // Вестник РАМН. 1997. No 6. С. 37–42.; Тычинский В.П. Когерентная фазовая микроскопия внутриклеточных процессов // Успехи физических; наук. 2001. Т. 171, No 6. С. 649–662.; Ченцов Ю.С. Введение в клеточную биологию. М.: Академкнига, 2005.; Шумаков В.И., Мойсюк Я.Г., Томилина Н.А. Трансплантация почки // Нефрология: Руководство для врачей / Под ред. И.Е. Тареевой. М.: Медицина, 2000. С. 658–682.; Butani L., Johnson J., Troppmann C. et al. Predictive value of pretransplant inflammatory markers in renal al- lograft survival and rejection in children // Transplant. Proc. 2005. Vol. 37, No 2. P. 679–681.; Diaz I., Sanchez P., Alonso C., Valdes F. Immunologi- cal profile of patients awaiting a renal transplant // Clin. Transplant. 2004. Vol. 18, No 5. Р. 529–535.; Divate S.A. Acute renal allograft rejection: progress in understanding cellular and molecular mechanisms // Transplantation. 2000. Vol. 46, No 4. P. 293–296.; Kang N., Guan D., Xing N. et al. Expression of CD158b on peripheral blood lymphocytic cell after kidney transplantation // Transplant. Proc. 2005. Vol. 37, No 2. P. 782–784.; Kishimoto K., Sandner S., Imitola J. et al. Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance // J. Clin. Invest. 2002. Vol. 109, No 11. P. 1471–1479.; Posselt A.M., Vincenti F., Bedolli M. et al. CD69 expres- sion on peripheral CD8 T cells correlates with acute re- jection in renal transplant recipients // Transplantation. 2003. Vol. 76, No 1. P. 190–195.; Reinsmoen N., Cornett K.J., Matas A., Savik K. Determ- ing level of immunological risk for early graft dysfunc- tion using pretransplant immune response indicators // Abstracts of the World Transplant Congress, July 22–27, 2006, Boston. 696 р.; Sarwal M., Chua M.S., Kambham N. et al. Molecular heterogeneity in acute renal allograft rejection idettified by DNA microarray profiling // N. Engl. J. Med. 2003. Vol. 349, No 2. P. 125–138.; Sarwal M., Jani A., Chang S. et al. Granulysin expres- sion is a marker for acute rejection and steroid resistance in human renal transplantation // Hum. Immunol. 2001. Vol. 62, No 1. P. 21–31.; Tinckam K.J., Wood I.G., Ji F., Milford E.L. ATG induc- tion is associated with an increase in anti-HLA antibod- ies after kidney transplantation // Hum. Immunol. 2004. Vol. 65, No 11. P. 1281–1287.; https://journal.transpl.ru/vtio/article/view/263

الاتاحة: https://journal.transpl.ru/vtio/article/view/263
https://doi.org/10.15825/1995-1191-2009-4-18-25

المؤلفون: L. V. Shkalova, N. P. Mogeiko, I. M. Iljinsky, Y. G. Moysyuk, O. M. Tsirulnikova, S. V. Gautier, Л. В. Шкалова, Н. П. Можейко, И. М. Ильинский, Я. Г. Мойсюк, О. М. Цирульникова, С. В. Готье

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 13, № 3 (2011); 15-19 ; Вестник трансплантологии и искусственных органов; Том 13, № 3 (2011); 15-19 ; 2412-6160 ; 1995-1191 ; 10.15825/1995-1191-2011-3

مصطلحات موضوعية: морфология, acute rejection, morphology, острое отторжение

وصف الملف: application/pdf

Relation: https://journal.transpl.ru/vtio/article/view/410/352; Готье С.В., Константинов Б.А., Цирульникова О.М. Трансплантация печени // Руководство для врачей. М.: Медицинское информационное агентство, 2008. 248 с.; Abraham S.C., Freese D.K., Ishitani M.B. et al. Signifi- cance of central perivenulitis in pediatric liver transplan- tation // Am. J. Surg. Patol. 2008. V. 32 (10). P. 1479– 1488.; Berenguer M., Rayon M., Prieto M. et al. Are post- transplantation protocol liver biopsies useful in the long- term? // Liver Transpl. 2001. Vol. 23. P. 234–241.; Demetris A.J., Ruppert K., Dvorchik I. et al. Real- time monitoring of acute liver allograft rejection using the Banff schema // Transplantation. 2002. V. 74 (9). P. 1290–1296.; Dixon L.R., Crawford J.M. Early histologic changes in fibrosing cholestatic hepatitis C // Liver Transplantation. 2007. V. 13 (2). P. 219–226.; Gornicka В., Ziarkiewicz-Wroblewskaa B., Bogdans- kaa M. et al. Pathomorphological Features of Acute Re- jection in Patients After Orthotopic Liver Transplantati- on: Own Experience // J. Transplantation Proceedings. 2006. V. 38 (1). P. 221 –225.; Gouv A.S., van den Heuvel M.C., van den Berg A.P., Sloff M.J. et al. Significance of parenchemymal changes of acute cellular rejection in predicting chronic liver graft rejection // Transplantation. 2002. V. 73 (2). P. 243–247.; Hassoun Z., Shah V., Lohse C.M., Pankratz V.S., Pet- rovic L.M. Centrilobular necrosis after orthotopic liver transplantation: association with acute cellular rejection and impact on outcome // Liver Transpl. 2004. V. 10 (4). P. 480–487.; Höroldt B.S., Burattin M., Gunson B.K. et al. Does the Banff rejection activity index predict outcome in pati- ents with early acute cellular rejection following liver transplantation? // Liver transplantation. 2006. V. 12 (7). P. 1144–1151.; Hubscher S.G. Transplantation pathology // Semin Liver Dis. 2009. V. 29 (1). P. 74–90.; International Panel. Banff schema for grading liver al- lograft rejection: an international consensus document // Hepatology. 1997. V. 25. P. 658–663.; InternationalWorkingParty.Terminologyforhepatical- lograft rejection // Hepatology. 1995. V. 22. P. 648–654.; Krasinskas A.M., Demetris A.J., Poterucha J.J., Abra-; ham S.C. The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers // Liver Transpl. 2008. V. 14 (5). P. 625–632.; Lovell M.O., Speeg K.V., Halff G.A., Molina D.K. et al. Acute hepatic allograft rejection: a comparison of pa- tients with and without centrilobular alterations during first rejection episode // Liver Transpl. 2004. V. 10 (3). P. 369–373.; Neil D.A.H., Hübscher S.G. Current views on rejection pathology in liver transplantation // Transplant Internati- onal. 2010. V. 23 (10). P. 971–983.; Regev A., Molina E., Moura R. et al. Reliability of histopa- thologic assessment for the differentiation of recurrent he- patitis C from acute rejection after liver transplantation // Liver Transplantation. 2004. V. 10 (10). P. 1233–1239.; Stravitz R.T., Shiffman M.L., Sanyal A.J. et al. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation // Liver Transpl. 2004. V. 10. P. 850–858.; https://journal.transpl.ru/vtio/article/view/410

الاتاحة: https://journal.transpl.ru/vtio/article/view/410
https://doi.org/10.15825/1995-1191-2011-3-15-19

المؤلفون: Kapishnikov A.V., Kolsanov A.V., Pyshkina Y.S.

المصدر: Annals of the Russian academy of medical sciences; Vol 69, No 11-12 (2014); 89-96 ; Вестник Российской академии медицинских наук; Vol 69, No 11-12 (2014); 89-96 ; 2414-3545 ; 0869-6047 ; 10.15690/vramn6911-12

مصطلحات موضوعية: kidney transplantation, dynamic renal scintigraphy, postrenal transplantation complications, acute rejection, chronic nephropathy, трансплантация почки, динамическая сцинтиграфия почек, посттрансплантационные осложнения, острое отторжение, хроническая нефропатия

وصف الملف: application/pdf

Relation: https://vestnikramn.spr-journal.ru/jour/article/view/375/313; https://vestnikramn.spr-journal.ru/jour/article/view/375

الاتاحة: https://vestnikramn.spr-journal.ru/jour/article/view/375
https://doi.org/10.15690/vramn.v69i11-12.1189

المؤلفون: Капишников, Александр, Колсанов, Александр, Пышкина, Юлия

مصطلحات موضوعية: ТРАНСПЛАНТАЦИЯ ПОЧКИ, ДИНАМИЧЕСКАЯ СЦИНТИГРАФИЯ ПОЧЕК, ПОСТТРАНСПЛАНТАЦИОННЫЕ ОСЛОЖНЕНИЯ, ОСТРОЕ ОТТОРЖЕНИЕ, ХРОНИЧЕСКАЯ НЕФРОПАТИЯ

وصف الملف: text/html

الاتاحة: http://cyberleninka.ru/article/n/radionuklidnaya-vizualizatsiya-pri-otsenke-funktsionalnogo-sostoyaniya-peresazhennoy-pochki-v-posttransplantatsionnom-periode
http://cyberleninka.ru/article_covers/15702538.png

المؤلفون: Ватазин, А., Круглов, Е., Астахов, П., Зулькарнаев, А., Федулкина, В.

مصطلحات موضوعية: ТРАНСПЛАНТАЦИЯ ПОЧКИ, БАКТЕРИАЛЬНЫЕ ИНФЕКЦИИ, ФАКТОРЫ РИСКА, ВЫЖИВАЕМОСТЬ ТРАНСПЛАНТАТОВ, ВЫЖИВАЕМОСТЬ РЕЦИПИЕНТОВ, ОСТРОЕ ОТТОРЖЕНИЕ

وصف الملف: text/html

الاتاحة: http://cyberleninka.ru/article/n/bakterialnye-infektsii-i-dolgosrochnye-rezultaty-transplantatsii-pochki
http://cyberleninka.ru/article_covers/15136787.png

المؤلفون: Федулкина, В., Ватазин, А., Кильдюшевский, А., Столяревич, Е., Кантария, Р., Зулькарнаев, А.

مصطلحات موضوعية: АЛЛОТРАНСПЛАНТАЦИЯ ТРУПНОЙ ПОЧКИ, ОСТРОЕ ОТТОРЖЕНИЕ ПОЧЕЧНОГО АЛЛОТРАНСПЛАНТАТА, ТРАНСЛЯЦИОННАЯ КЛЕТОЧНАЯ ИММУНОТЕРАПИЯ, ПРОТОКОЛЬНАЯ БИОПСИЯ ПОЧЕЧНОГО АЛЛОТРАНСПЛАНТАТА

وصف الملف: text/html

الاتاحة: http://cyberleninka.ru/article/n/translyatsionnaya-kletochnaya-immunoterapiya-pri-allotransplantatsii-trupnoy-pochki-u-urologicheskih-bolnyh
http://cyberleninka.ru/article_covers/15122419.png

المؤلفون: Орлова, Ольга

مصطلحات موضوعية: НЕОПТЕРИН, СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ, ТРАНСПЛАНТАЦИЯ СЕРДЦА, ОСТРОЕ ОТТОРЖЕНИЕ, ИНФЕКЦИЯ

وصف الملف: text/html

الاتاحة: http://cyberleninka.ru/article/n/neopterin-u-bolnyh-serdechnoy-nedostatochnostyu-i-retsipientov-serdtsa
http://cyberleninka.ru/article_covers/14131441.png

المؤلفون: A.V Trailin, T.N. Nikonenko, T.I. Ostapenko, N.N. Polyakov, A.S. Nikonenko, А.В. Траилин, Т.Н. Никоненко, Т.И. Остапенко, Н.Н. Поляков, А.С. Никоненко

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 11, № 2 (2009); 29-36 ; Вестник трансплантологии и искусственных органов; Том 11, № 2 (2009); 29-36 ; 2412-6160 ; 1995-1191 ; 10.15825/1995-1191-2009-2

مصطلحات موضوعية: трансплантация почки, острое отторжение, C4d-компонент комплемента

وصف الملف: application/pdf

Relation: https://journal.transpl.ru/vtio/article/view/179/121; Böhmig G.A., Wahrmann M., Regele H. et al. Immunoadsorption in severe C4d-positive acute kidney allograft; rejection: a randomized controlled trial // Am. J. Transplant. 2007. V. 7. № 1. P. 117–121.; Colvin R.B. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis // J. Am. Soc. Nephrol. 2007.; V. 18. № 4. Р. 1046–1056.; Cornell L.D., Smith R.N., Colvin R.B. Kidney Transplantation: Mechanisms of Rejection and Acceptance // Annu. Rev. Pathol. Mech. Dis. 2008. V. 3. P. 189–220.; Girlanda R., Kleiner D.E., Duan Z. et al. Monocyte Infi ltration and Kidney Allograft Dysfunction During Acute Rejection // Am. J. Transplant. 2008. V. 8. P. 600–607.; Feucht H.E., Schneeberger H., Hillebrand G. et al. Capillary deposition of C4d complement fragment and early renal graft loss // Kidney Int. 1993. V. 43. P. 1333–1338.; Hadley G. Role of integrin CD103 in promoting destruction of renal allografts by CD8 T cells // Am. J. Transplant.; V. 4. P. 1026–1032.; Hariharan S., Johnson C.P., Bresnahan B.A. et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996 // N. Engl. J. Med. 2000. V. 342. P. 605–612.; Kirk A.D., Mannon R.B., Kleiner D.E. Monocytes, not T-cells, primarily determine the functional signifi cance of a rejection // Abstracts of the World Transplant Congress. Boston. July 22–27. 2006. P. 409.; Matheson P.J., Dittmer I.D., Beaumont B.W. et al. The macrophage is the predominant infl ammatory cell in renal; allograft intimal arteritis // Transplantat. 2005. V. 79. P. 1658–1662.; Mauiyyedi S., Crespo M., Collins B.A. et al. Acute humoral rejection in kidney transplantation: II. Morphology; immunopathology, and pathologic classifi cation // J. Am. Soc. Nephrol. 2002. V. 13. P. 779–787.; Mengel M., Chapman J.R., Cosio F.G. et al. Protocol biopsies in renal transplantation: Insights into patient management and pathogenesis // Am. J. Transplant. 2007. V. 7. P. 512–517.; Nickeleit V., Zeiler M., Gudat F. et al. Detection of the Complement Degradation Product C4d in Renal Allografts; Diagnostic and Therapeutic Implications // J. Am. Soc. Nephrol. 2002. V. 13. P. 242–251.; Racusen L.C., Colvin R.B., Solez K. et al. Antibody-mediated rejection criteria- an addition to the Banff-97 classifi; cation of renal allograft rejection // Am. J. Transplant. 2003. V. 3. P. 708–714.; Racusen L.C., Solez K., Colvin R.B. et al. The Banff-97 working classifi cation of renal allograft pathology // Kidney; Int. 1999. V. 55. № 2. P. 713–723.; Solez K., Colvin R.B., Racusen L. et al. Banff-05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (‘CAN’) // American Journal of Transplantation. 2007. V. 7. P. 518–526.; Srinivas T.R., Kubilis P.S., Croker B.P. Macrophage index predicts short-term renal allograft function and graft; survival // Transpl. Int. 2004. V. 17. P. 195–201.; Tinckam K.J., Djurdjev O., Magil A.B. Glomerular monocytes predict worse outcomes after acute renal allograft; rejection independent of C4d status // Kidney Int. 2005. V. 68. P. 1866–1874.; van der Woude F.J., Deckers J.G., Mallat M.J. et al. Tissue antigens in tubulointerstitial and vascular rejection //; Kidney Int. Suppl. 1995. V. 52. S11–S13.; Veronese F.V., Noronha I.L., Manfro R.C. et al. Pevalence and immunohistochemical fi ndings of subclinical kidney; allograft rejection and its association with graft outcome. Clin. Transplant. 2004. V. 18 (4). P. 357–364.; Wyburn K.R., Jose M.D., Wu H. et al. The role of macrophages in allograft rejection // Transplantat. 2005. V. 80.; P. 1641–1647.; Yilmaz S., Gonul I., Sar A. et al. Does interstitial infl ammation have a value in the Banff-97 chronic/sclerosing; lesion scoring? In: Abstracts of the World Transplant Congress. Boston. July 22–27, 2006. P. 457–458.; https://journal.transpl.ru/vtio/article/view/179

الاتاحة: https://journal.transpl.ru/vtio/article/view/179
https://doi.org/10.15825/1995-1191-2009-2-29-36

المؤلفون: Бутрин, С., Перлин, Д., Иванов, П., Яровой, С., Дударева, А.

مصطلحات موضوعية: ТРАНСПЛАНТАЦИЯ ПОЧКИ, ОСТРОЕ ОТТОРЖЕНИЕ ТРАНСПЛАНТАТА, ПРЕПАРАТЫ ПОЛИИ МОНОКЛОНАЛЬНЫХ АНТИЛИМФОЦИТАРНЫХ АНТИТЕЛ

وصف الملف: text/html

الاتاحة: http://cyberleninka.ru/article/n/lechenie-ostrogo-ottorzheniya-posle-transplantatsii-pochki-s-ispolzovaniem-poli-i-monoklonalnyh-antitel-k-limfotsitam-cheloveka
http://cyberleninka.ru/article_covers/14333548.png

المؤلفون: Райниене, Т., Асакиене, Е., Зелвис, А.

مصطلحات موضوعية: ОТСРОЧЕННАЯ ФУНКЦИЯ ТРАНСПЛАНТАТА, ОСТРОЕ ОТТОРЖЕНИЕ (КРИЗИС ОТТОРЖЕНИЯ), ФУНКЦИЯ (АЛЛО)ТРАНСП-ЛАНТАТА, ВЫЖИВАЕМОСТЬ ПАЦИЕНТОВ И ТРАНСПЛАНТАТА

وصف الملف: text/html

الاتاحة: http://cyberleninka.ru/article/n/vliyanie-otsrochennoy-funktsii-transplantata-na-vyzhivaemost-v-techenie-goda-posle-transplantatsii
http://cyberleninka.ru/article_covers/15283994.png